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Abstract
Diabetic foot ulcers (DFU) are one of the most challenging complications associated with
diabetes mellitus (DM). Every 1 in 4 patients with DM are expected to develop an ulcer
in their life time. The time course of healing is on average 90 to 120 days which increases
the risks of infection, amputations and death. Nitric oxide (NO) is a signaling molecule
produced in the body that has been established in the literature to serve many roles in the
body, including as a vasodilator, neurotransmitter immune modulator and antimicrobial
agent. Emerging evidence has shown that NO is indispensable in every stage of wound
healing and its dysregulation is a major hinderance in the healing of DFU. The problem
associated with harnessing the biological effects of NO is that it is very reactive and
consequently it is extremely difficult to measure. As a result, majority of the studies in the
literature measure its metabolic products (nitrate and nitrite) to correlate NO function. The
challenge with relying on NO metabolites is that they can only be analyzed at static time
points as an accumulation measure and they do not give any information about the dynamic
NO changes taking place in the wound environment. Moreover, the NO dose produced by
specific cells during the course of cell migration and proliferation varies depending on the
stage of wound healing. The function of NO is very complex with its effects ranging from
protective to deleterious depending on the dose and duration of the treatment and even the
surrounding host environment. It is therefore of paramount importance to understand the
real-time NO profile produced and exposed to the cells that are actively involved in the
wound healing process and to analyze how the profile changes in physiological and
pathological conditions. This dissertation presents the real-time NO levels produced from
normal and chronic wound fibroblast cells cultured in normal and high glucose conditions
when stimulated by inflammatory mediators that are commonly present in the wound
environment. The results showed that the real-time NO levels produced by fibroblasts are
higher in normal glucose compared to high glucose cell culture conditions (8.42±1.16 vs
3.26±0.79 nmols/105 cells). The real-time NO levels were significantly increased in normal
glucose with stimulation compared to normal glucose without stimulation. High glucose
conditions in the absence and presence of stimulation showed no statistical difference
between the two groups. The NO levels produced by fibroblasts obtained from biopsy
samples from patients treated at a chronic wound care clinic was suppressed. Overall there
was no statistical difference within the experimental groups. The NO levels produced by
the cells did not correlate with the nitrite and nitrate detected in the fluid obtained from the
wound site (nanomolar vs micromolar concentration respectively). The results were
compared with the well characterized macrophage cell line RAW 264.7 which also showed
higher NO levels (161.80± 29.05 vs 46.30±12.9 nmols/106 cells) in normal glucose
compared to high glucose conditions and no statistical difference in the nitrite levels in
normal and high glucose conditions. The results clearly indicate the need for real-time NO
monitoring to determine the level and duration of NO production by cells in the wound bed
and that the use of nitrite and nitrate does not provide accurate information regarding NO
dysregulation in chronic non-healing wounds. The work presented herein will facilitate the
development of treatments that address not only the actual dose of NO treatment needed in
the wound but also potentially indicate factors that may interfere with the NO function.
xii

1 INTRODUCTION
Diabetes mellitus (DM) is by far the most prevalent and one of the most challenging
non communicable disease[1] currently dealt in the world. In 2000, the estimated
number of people living with DM worldwide was 151 million with costs of treatment
greater than $44 billion in the United States alone [1]. The population affected was
predicted to go up to 300 million in 2025[2]. However, as of 2017, the global
prevalence of diabetes has already risen to 425 million with increased healthcare costs
of US$ 727 billion. Currently, it is predicted to affect 629 million people by 2045[3].
DM encompasses a group of metabolic conditions that result in high glucose levels (>
7Mm) [4]. It exists in 4 main categories; DM type 1, DM type 2 , gestational DM and
genetic defects in the beta cell function DM[5]. The most predominant being type 1
and type 2 DM. DM Type 1 is mainly an autoimmune disease of the younger population
that causes destruction of pancreatic beta cells and reduced production of insulin that
is necessary for glucose metabolism[6]. A common finding in patients is the presence
of the histocompatibility antigen HLA-DR3/DR4. Other risk factors include;
environmental exposures, gender differences, ethnicity, infections, seasonal variation
and location[2]. DM Type 2 is characterized by the inability to maintain fuel hemostasis
due to hyperglycemia and altered lipid metabolism. There is no destruction of the islet
cells. However, there is inadequate insulin production and negative body responses
resulting from over nutrition, obesity and inactivity[7]. In contrast, it mainly affects the
older population although the risk factors remain similar to type 1 DM. More recently
it has become more prevalent among the younger population especially in North
America (10-14 years) [8]. In almost all DM patients, the high circulating blood glucose
levels (hyperglycemia) causes a multi organ effect that can lead to complications on a
micro (neuropathy, retinopathy and nephropathy) and macro vascular scale (coronary
artery disease, stroke and peripheral vascular disease). The prevalence and mechanisms
of each of these complications can be found elsewhere[9-13]. This dissertation focuses
on peripheral vascular disease with emphasis on diabetic foot ulcers (DFU).
It is reported that every 1 in 4 people living with DM will develop a foot ulcer. In the
US, 1 million cases of diabetic foot ulcer complications were recorded in various
emergency departments from 2006-2010. The costs of treatment for both in care and
out care patients in 2014 surpassed 10 billion dollars[14]. Unfortunately, the clinical
outcomes of DFU are very grim. The main reason is the prolonged healing time which
on average is about 90-120 days [15]. This increases the risk of infection resulting in
sepsis, amputation and death [16]. (Figure 1-1). Additionally, these non-healing
wounds have a significant negative impact on a patient’s lifestyle [17].

1

Figure 1-1 The prevalence and clinical outcomes of DFU

1.1 The physiological wound healing process and alterations in
DFU
Wound healing proceeds in 4 complex and overlapping stages; hemostasis,
inflammation, proliferation and remodeling [18-21](Figure 1-2). The duration can vary
depending on the injury, age, genetic makeup and co morbidities of the individual[21].
However, in majority of cases, it is approximately 3 weeks[22].
During the first 24 hours following injury, platelets are released at the wound site, and
in the presence of a number of extrinsic and intrinsic factors, a fibrin plug is formed
preventing blood loss and infection. The fibrin plug provides a provisional matrix
scaffold for the migration of immune cells[22]. The platelets also release growth factors
such as platelet derived growth factor (PDGF), insulin like growth factor (IGF),
epidermal growth factor (EGF) and transforming growth factor-Beta (TGF-ẞ) that are
essential for recruiting inflammatory cells at the wound site[23].
The arrival of immune cells, marks the beginning of the acute inflammatory phase,
which peaks at 24 hours and lasts 3-4 days[24]. The capillaries dilate and become more
permeable through mediation by prostaglandins (PG) specifically; PGI2, PGD2 and
PGE2. Vasodilation will slow down the blood flow in the post capillary venules
allowing transmigration to take place. Circulating neutrophils align on the basement
membrane, selectins P and E are upregulated on the endothelial cells that line the blood
2

vessels, which makes it possible for the neutrophils to slow down and cross the
basement membrane into the affected tissue space. Other neutrophil chemotactic agents
such as; leukotriene B4 (LTB4), complement component 5a (C5a), Tumor necrotic
factor-alpha (TNF-α), TGF-ẞ, platelet factor 4 (PF4), interleukin1 (IL1), interleukine
8 (IL8), and bacterial products further facilitate neutrophil recruitment at the wound
site[24, 25]. Neutrophils produce hypochlorous acid (HClO)
through the
myeloperoxidase pathway to sterilize the wound[26]. In addition, neutrophils cleanse
the wound of necrotic debris by forming a phagolysosome. To modulate the acute
immune response, platelets will adhere to neutrophils and through the 5-lipoxygenase
pathway, the association will lead to the formation of lipoxins A4 and B4 that act as a
checkpoint to stop the infiltration of neutrophils.[26, 27]Circulating blood monocytes
will migrate to the wound and differentiate into macrophage cells. Macrophages coordinate host defense, immune response and direct the wound healing process by
taking on two opposite polarized forms, both of which can be lethal if overly expressed;
M1 (kill function) and M2 (heal function)[28, 29]. The granulocyte macrophage and
macrophage colony stimulating factors (GM-CSF and M-CSF) are key players that
initiate macrophage polarization into classically (M1) and alternatively (M2) activated
macrophages respectively [29, 30]. In the next 2-3 days following hemostasis, the
predominant phenotype is M1. The function of M1 is enhanced in the presence of
inflammatory mediators’ interferon-Ƴ (IFN-Ƴ), TNF-α and bacterial products
lipopolysaccharide (LPS). M1 produce large amounts of superoxide and express the
inducible nitric oxide synthase enzyme (iNOS), which generate nitric oxide (NO) from
the conversion of the amino acid L-arginine into L- citrulline [31, 32].NO and
superoxide are responsible for the antimicrobial properties of M1 and will be discussed
later in this project. Other roles of M1 include clearing the wound bed of necrotic tissue
and microbial products by phagocytosis[33].M1 also recruit Th1 cells which are
involved in the adoptive immune response. TH1 are responsible for the destruction of
intracellular parasites and produce high levels of the proinflammatory cytokine IFNƳ[34]. When the wound is sterile, macrophages switch to M2 that counteract the proinflammatory effects of M1 cells through activation of Th2 cells[33]. Th2 secrete the
anti-inflammatory cytokines IL-4, 5, IL-10 and IL-13[34]. M2 are further activated by
IL-4 produced by TH2 cells, eosinophils and basophils. Glucocorticoids secreted from
the adrenal gland also activate M2 cells[33]. Interestingly, M2 also utilize the amino
acid arginine to produce ornithine via the enzyme arginase-1. Ornithine promotes cell
growth, collagen production and tissue repair[29, 30]. In a rat model, M2 macrophages
appeared on day 7 of healing in healthy rats, and it also marked the beginning of the
proliferation stage of wound healing[35]. Growth factors PDGF and EGF produced by
both macrophages and platelets attract the migration and proliferation of fibroblast cells
from the wound edge[25]. Fibroblast cells deposit extracellular matrix (ECM) that is
indispensable for re-epithelialization and tissue remodeling to take place. The initial
components of the matrix produced are collagen type 3, glycosaminoglycans (GAGs),
specifically chondroitin sulphate, tenascin and fibronectin [36, 37]. Fibronectin
promotes adhesion of the cells to the fibrin scaffold deposited by the platelets[37]. The
hydration capacity of chondroitin sulphate increases the mechanical strength and serves
as a temporary matrix during the first two weeks of healing[36]. Tenascin regulates
3

the cell shape and therefore function of the cell. In addition, tenascin plays a role in
maintaining the tissue hemostasis [36, 38]. Ploeger et al[39] demonstrated that like
macrophages, fibroblasts also exhibit an element of plasticity depending on the
polarized form of macrophages. In this study, human dermal fibroblasts cultured in M1
conditioned media upregulated inflammatory cytokines in fibroblasts and increased
their ability to degrade the ECM while fibroblasts cultured in M2 conditioned media
had the inverse effect. This strongly suggests that in the early phases of wound healing,
a more compliant matrix is necessary to allow the free movement of cells to their
destinations as well as sprouting of vessels to ensure adequate nutrition for the growth,
maintenance and function of the cells. Matrix metalloprotease enzymes (MMPS)
secreted by macrophages, fibroblasts (collagenases, gelatinases, stromelysin) and
plasmin present in the serum are responsible for the breakdown of the ECM[40]. In
addition, MMPS modulate the inflammatory response through the degradation and
activation of chemokines[41]. The activity of MMPS is in turn also regulated by tissue
inhibitors of matrix metalloprotease enzymes (TIMPS) produced from fibroblasts that
are stimulated by TGF-ẞ and IL-6. Studies also show that fibroblast cells produce low
levels of NO [42-44]. However, the specific role of the NO produced still needs to be
determined.
The proliferation and migration of fibroblasts initiates the granulation/remodeling
stage. The former flexible matrix is gradually replaced by a stiffer and more permanent
scaffold. This is the most important phase of the healing process because it determines
the risk of recurrent injury depending on the matrix that is deposited. Several factors
are involved and the concentration of each one needs to be precisely controlled to
facilitate the formation of an appropriately organized and mechanically sound tissue.
The benefit is to maintain isometric tension which prevents the shortening and
lengthening of cells during the remodeling process. The switch from M1 to M2
macrophages promotes the production of ECM by fibroblasts. TGF-ẞ produced from
M2 stimulates the production of collagen type 1 [25, 45]. The permanent matrix that
is formed is composed mainly of type 1 (80-90%) which increases the wound breaking
strength. Moreover, TGF-ẞ mediates the transformation of fibroblasts into
myofibroblasts that are responsible for wound contracture[46]. Other formed elements
of the ECM include elastin which adds resilience and elasticity to the wound. In
addition, the cleavage of elastin by MMPS releases tropoelastin that helps in the
attachment, spreading and proliferation of fibroblasts[47]. The granulation/remodeling
stage can last about a year and the scar that is formed will only achieve 80% strength
of the uninjured skin tissue under physiological wound healing conditions[25].
A key feature in wound healing is epithelialization. This is the process of covering a
denuded epithelial surface and
is critical to achieve wound closure [48]
Epithelialization starts as early as day 4 during wound healing. The cytokines IL-1 and
TNF-α stimulate fibroblasts to produce keratinocyte growth factors (KGF) 1, 2 and IL6 which attract the keratinocyte cells at the wound edge[25]. Epithelialization is a layer
by layer process that requires keratinocyte cells to detach from the basal layer, migrate
and proliferate across the newly formed matrix of the wound bed to allow a sufficient
4

cell density to close off the wound[49] (Figure 1-2). The degradation of the ECM by
MMPs releases and activates growth factors that promote proliferation of keratinocyte
cells. These growth factors include: EGF, TGF-α, KGF and heparin-binding EGF-like
growth factor[50]. The keratinocytes also promote angiogenesis by secreting vascular
endothelial growth factor (VEGF) and IL4. When the migrating/proliferating
keratinocytes from both ends of the wound meet, they cease to proliferate (contact
inhibition)[51]. In addition, growth factors like TGF-ẞ synthesized by the fibroblast
cells, stop the proliferation of keratinocytes by causing a switch from activated to basal
keratinocyte phenotypes [49, 52]. Thereafter, cornification begins in the supra basal
layer. Cornification is an elegant form of cell death. It proceeds with keratinocyte cells
switching to a terminally differentiating phenotype accompanied by the synthesis of
cornified envelope structural proteins and lipids that are covalently bonded by specific
transglutaminases to form a spinous, granular and desquamous layer that acts as a
barrier against the hostile external environment [52]. Epithelialization usually lasts
approximately 2 weeks [53].

Figure 1-2. The physiology of wound healing
The successful closure of a wound involves an intricately coordinated cross talk
between immune cells and resident cells such as the keratinocyte and fibroblasts that
allows temporal and spatial control over the production and function of the different
elements required for the formation of healthy tissue. The harmony of this wound
environment relies greatly on metabolic, chemical, and mechanical cues that are
significantly altered in DFU that leads to impaired healing.
The diabetic foot is a metabolic disorder characterized by a pathological triad;
neuropathy ischemia, and infection that results in the development of a chronic
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ulcer[54], which is a breakdown in the skin that extends from the surface to the
subcutaneous tissue, muscle and bone[55]. It is termed chronic when it does not heal
in an orderly or timely manner and does not result in structural integrity[56].
In the mitochondria, hyperglycemia causes an abnormally high membrane potential.
Above the threshold, electron transport at complex III of the electron transport chain is
inhibited with an increase in the half-life of the co- enzyme Q that reduces oxygen to
superoxide. Superoxide inhibits the glycolytic enzyme glyceraldehyde-3-phosphate
dehydrogenase (GAPDH) causing an increase in the glucose flux and enhancement of
the polyol pathway[57]. The result is the consumption of NADPH that is needed for
the regeneration of antioxidant molecules such as glutathione. In the absence of
antioxidants, there is an accumulation of reactive oxygen and nitrogen species (ROS
and RNS) which activate the master transcription factor of inflammation, nuclear factor
kappa beta (NF-kβ) [58, 59]. NF-kβ influences gene expression and the production of
number of chemokines namely IL-1, IL-6 and TNF-α [60]. The latter proteins lead to
insulin resistance further aggravating hyperglycemia[61]. The increase in oxidative
stress induces nerve damage, impairs vascular reflexes, peripheral vasodilation and
bone resorption. All these factors augment the likelihood of a bone fracture and foot
deformity consequently increasing the risk of foot trauma. Moreover, the loss of
sensation that accompanies neuropathy also increases susceptibility to injury for the
patient. Glucose binds to residue amino groups on polypeptides and lipids to form
advanced glycation end products (AGEs)[62]. AGEs bind to the receptor of advanced
glycation end products (RAGE) on endothelial cells, vascular smooth muscle cells and
macrophages, which in turn also activate NF-kβ[61, 63]. Glycation of the structural
proteins collagen and laminin found in the basement membrane of the blood vessels
impairs the electric charge and leads to increased membrane permeability and stiffening
of the vessel wall[64]. The effect is most pronounced in the microcirculation where it
leads to an increase in hydrostatic pressure and shear forces resulting in the injury of
the endothelium lining. There is a release of extravascular matrix proteins that leads to
basement membrane thickening[65]. In the event of a foot injury, the thickened vessel
makes it difficult for immune cells to migrate to the affected area and also increases the
risk of infection that hinders the healing of the ulcer. Neuropathy also reduces the
formation of neuropeptide proteins (nerve growth factor, calcitonin, substance p that
are involved in recruiting cells to the wound site[66]. Poor cell infiltration is
accompanied by a deficiency in growth factors and molecules that are required for the
ideal symphony of events that lead to wound regression.
Advanced treatments have been developed that take advantage of the different factors
(Mechanical, chemical and biological cues) involved in the physiological wound
healing process. These include; Silver impregnated dressing (Aquacel Ag®) which
effectively cleanses the wound of infection while absorbing excess exudate and
maintaining a moist environment ideal for wound healing[67]. Medihoney® gel
dressing that acts as debridement agent and lowers the pH at the wound site[68].
Polyurethane foam (Allevyn®) facilitates gaseous exchange and absorbs excess
exudate which facilitates the healing process[69]. Hydrogels also provide a moist
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environment ideal for healing and lowers the temperature at the wound site[69]. Other
dressings incorporate collagen and growth factors (PDGF and EGF)[70, 71]
consequently providing a suitable milieu for the formation of granulation tissue.
Unfortunately, none of these dressing have resulted in an adequate response or healing
time for diabetic foot ulcers[72].

1.2 The role of NO in wound healing and its alterations in DFU
Nitric oxide is a gaseous molecule that was first characterized by Joseph Priestly in 1772
and before 1980 was viewed mainly as an air pollutant present in automobile exhaust and
cigarette smoke. However, as a result of the work done by Robert Furchgott, Louis Ignarro,
Marek Radomski and Ferid Murad, it is now well known in the literature for its myriad of
roles in maintaining vascular homeostasis, inhibition of inflammation and bacterial
invasion, facilitating wound healing and as an intercellular signaling molecule involved in
neurotransmission [73-76]. In the body, NO is primarily produced via a metabolic pathway
involving L-arginine, Ca2+/calmodulin, oxygen, nicotinamide adenine dinucleotide
phosphate (NADPH), tetrahydrobiopterin (BH4) and one of three nitric oxide synthase
(NOS) isoform enzymes depending on the tissue and cell type. The NOS enzyme aids in
the transfer of electrons from NADPH in its carboxyl terminal reductase domain to the
heme in the amino-terminal oxygenase domain. This domain binds oxygen and BH4. The
heme reduces oxygen and oxidizes L-arginine into L-citrulline and NO. Calmodulin is
required to facilitate the flow of electrons (Figure 1-3). All the isoforms can bind
calmodulin at different affinities depending on the intracellular calcium levels and binding
site structure on the enzyme. There are 3 NOS isoforms that have been identified so far.
NOS -1 (neuronal) and NOS-3(endothelial) are constitutively expressed in the cells of
origin and require increased calcium concentration to bind calmodulin (200-400 nM) while
NOS-2 (inducible) expression is induced by inflammatory mediators and is referred to as
calcium independent because it strongly binds calmodulin at very low calcium levels (<40
nM)[77] [78].
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Figure 1-3. The metabolic pathway of NO generation
In 1992, Heck et al reported the first production of NO in the skin by keratinocyte cells
when stimulated by inflammatory mediators[79]. The cells expressed NOS confirmed by
an enzyme activity assay. The maximal activity required both ca and calmodulin showing
probable dependence on constitutively expressed NOS isoforms. The production of NO
was observed to regulate the proliferation of keratinocyte cells. It was later confirmed that
keratinocytes constitutively express NOS-1 and can be induced to express NOS-2 as
well[80-82]. Since then, there have been several studies reporting NO production in the
skin when exposed to various stimulating factors as well as expression of the different NOS
isoforms in cells that are actively involved in the wound healing process (Table 1.1 ).
During hemostasis, NO produced from endothelial cells activates the enzyme guanylate
cyclase which initiates the cyclic c-GMP pathway to inhibit platelet aggregation and
enhance vasodilation. Endothelial cells express NOS-3 responsible for NO production. In
the inflammatory phase, M1 produce significant amounts of NO (>0.5mM) that acts to
destroy microbes and prevent infection of the wound. In fact, the highest NOS activity
occurs in the early phases of wound healing [31] and is predominantly produced from
macrophages. The NO levels are drastically reduced (0.01-0.25mM) when the wound
transitions to the proliferation stage [80, 83-85]. M1 convert to M2 macrophage cells that
do not produce NO. However, fibroblast cells produce low levels of NO (nanomolar range)
and express both NOS-1 and NOS-3 isoform enzymes[42, 43]. The low concentrations of
NO have a more anti-inflammatory effect on wound healing. A prime example is the
inhibitory effect on NF-κβ signaling. NO acts directly through S-nitrosylation of the p50
subunit of NF-κβ and inhibits its binding to DNA[86]. The NO produced in fibroblasts has
been shown to regulate collagen production[44]. It is also speculated that these low NO
levels produced from fibroblasts act as the first response before the immune cells arrive at
the wound site [43, 80]. The NO role in the proliferation of fibroblasts has not been well
established and its impact on their migration still needs to be determined. Low NO levels
also play a role in extracellular matrix remodeling/turnover. Ridnour et al demonstrated the
effect of NO treatment on modulating the activities of MMPS-1,9 and 13[87]. NO promotes
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angiogenesis through the activation of the growth factors VEGF, TGF and bFGF [88]. In
keratinocytes, the production of VEGF is controlled by NO production [89]. In addition,
NO has been shown to exert antiapoptotic effects through regulating the activity of
antiapoptotic markers such as HIF-1α [90] and inhibition of caspase activity [91]. It is
therefore conceivable that the doses of NO produced at the wound site change gradually
over the time course of healing to ensure that the production and regulation of growth
factors proceeds as expected to maintain the phenotype and the function of the cells at each
stage. (Figure 1-4).

Figure 1-4. The predicted nitric oxide levels produced from cells in the
different stages of wound healing
NO is highly reactive and very short lived and this dictates its overall effect on the cells.
In the presence of aggravating factors, there are mechanisms in place to maximize the
biological effect of NO in order to produce an appropriate host response. The most
important is the maintenance of nitroso-redox balance. If the stimulus persists or in case of
inadequate feedback, it alters the equilibrium of the wound environment, which is the
hallmark of dysregulated healing in DFU.
Table 1-1. The different NOS isoforms and their functions in cells types found in the skin
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TYPE

CELL

FUNCTION

REFERENCES

Neuronal/brain
(nNOS) 150160kD

Melanocytes,
keratinocytes
(basal epidermal
layer)

Vasodilation in response
to mechanical
stimulation,
Melanogenesis

[92-95]

Inducible
(iNOS) 130kD

Keratinocytes,
melanocytes
Fibroblasts,
macrophages,
Langerhans

Angiogenesis, collagen
production, wound
breaking strength,
immune response,
antimicrobial effects,
antiapoptotic effect

[80, 92]

Endothelial
(eNOS)

Endothelial cells
Keratinocytes,
melanocytes,
fibroblasts

Angiogenesis,

[80, 92]

135-140kD

Melanogenesis

1.2.1 Nitroso-redox balance in the pathophysiology of diabetic foot ulcers
Redox balance is determined by the change in the oxidative state of an atom[96]. An
addition of electrons results in reduction and a loss in electrons leads to oxidation[97]. An
imbalance between these two states causes oxidative stress that has deleterious effects on
the healing process. Reactive oxygen and nitrogen species (ROS and RNS) as well as
antioxidants are the major players in maintaining redox balance. Examples of ROS and
RNS include; superoxide (O.), hydrogen peroxide (H2O2), hydroxyl radical, hypochlorous
acid (HClO), nitric oxide (NO), and peroxynitrite (ONOO.).
1.2.1.1 Sources of ROS and RNS
Hydrogen peroxide formation
The spontaneous transfer of an electron to superoxide at low pH or by an enzyme reaction
(superoxide dismutase) produces hydrogen peroxide (H2O2)[98, 99]. H2O2 readily diffuses
across intra and intercellular membranes where it is involved in either cell signal
transduction or cytotoxic effects [99]. Hydrogen peroxide is a potent antimicrobial agent
at high concentrations (500 µM)[100]. In the inflammatory phase, H2O2 augments the
phosphorylating capacity of the enzyme tyrosine kinase which downstream amplifies the
signal at the antigen receptor site of the cell[101].
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Hydroxyl radical formation
The hydroxyl radical (.OH) can be formed from the reaction of H2O2 with superoxide
(Haber weiss reaction) or via the breakdown of H2O2 by metal ions; Fe2+ or Cu2+( Fenton
reaction) [102]. .OH is highly reactive, it interacts with DNA, lipids, proteins and
carbohydrates causing severe cell damage [103]. Although, a study has shown a dose
dependent effect of .OH on fibroblast function. The authors used an ascorbate-copper ion
system to generate hydroxyl radicals. Low levels (<10mumol/l) increased collagen
polymerization and high levels (>100mumol/l) evoked degradation of collagen showing a
possible role of .OH in remodeling of the ECM[104].
Hypochlorous acid formation
Hypochlorous acid is mainly produced by leuckocyte cells from the reaction of H2O2 with
chloride anions that originate from the uptake of extracellular fluid by the cell[105]. The
reaction is catalyzed by the enzyme myeloperoxidase (MPO) [24, 105]. HClO has very
strong antimicrobial effects and facilitates the removal of foreign particles and damaged
tissue. However, because of its cytotoxic effects it also affects the surrounding host
environment.

NO and peroxynitrite
Nitric oxide readily diffuses rapidly in water and lipids which makes its functions very
diverse. Its effects can be direct and indirect depending on the redox state. NO reacts with
metal ions such as ferrous heme to form a nitrosyl-heme complex. This mechanism is used
to activate the enzyme guanylate cyclase consequently converting GTP to cGMP which
downstream dictates majority of NO function especially in hemostasis[106]. NO also reacts
with the thiol groups in proteins through covalent post translational modification of
proteins[92] (s-nitrosylation). An example is the NO effect on transglutaminases by snitrosylation of the cysteine residues on their protein structure. Transglutaminases facilitate
the cross linking of the proteins in the ECM during epithelialization, proliferation and
remodeling[107]. The rate constant of both mechanisms is approximately 105-106 M -1 S -1.
In the presence of ROS specifically superoxide, indirect effects of NO manifest because it
rapidly reacts with superoxide at a rate that is faster than its reactions with proteins/metal
ions (1.9 x 1010 M-1 S -1 ) or the reaction of superoxide with the scavenger superoxide
dismutase (SOD) (2 X 10 9 M -1 S -1) [92] to form the more reactive and toxic compound
peroxynitrite[108] [58, 96]. At low concentrations, peroxynitrite acts as a signaling
molecule through activation of 3 tyrosine phosphorylation and the mitogen activated
protein kinases (MAPK) pathway which activates glycolysis and controls cell proliferation
respectively [58, 96] . In one study, it was shown to have antiapoptotic effects by inhibiting
caspase-3 activity through s nitrosylation in adhesion fibroblasts.[109]. Unfortunately, the
majority of peroxynitrite effects are cytotoxic. It modifies protein molecules by reacting
with the amino acids tyrosine and tryptophan to form nitrotyrosine and nitrotryptophan
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respectively. It also nitrates lipids and nucleic acids resulting in DNA damage. The damage
to DNA structure over activates the enzyme poly (ADP-ribose) polymerase-1 (PARP-1)
which consumes NAD+, ATP and eventually leads to cell dysfunction and death. At
physiological pH, peroxynitrite decomposes into more toxic species; nitrogendioxide and
hydroxyl radical [92].
1.2.1.2 Antioxidant mechanisms
To maximize the biological functions and reduce the accumulation and deleterious effects
of ROS and RNS, the body produces a variety of antioxidants. The toxic effects of
superoxide are controlled through dismutation by antioxidant enzymes SOD[58, 97].
Under physiological conditions, H2O2 levels are controlled through inactivation by the
enzyme glutathione peroxidase in the presence of the amino acid glutathione or the enzyme
catalase which convert H2O2 into oxygen and water [97]. Evidence shows that NO its selfacts as a substrate for MPO through the reaction with its end product NO2- which reduces
and inactivates the MPO compound 1[110]. Whether this could be a mechanism for
regulating HClO still needs to be investigated. Peroxynitrite accumulation can be
controlled by glutathione peroxidase in the presence of glutathione (GSH) which regulates
its cytotoxic effects[111]. Studies have shown an aggravated effect of hypovolemic shock
in case of increased toxicity by peroxynitrite and low GSH levels[112]. At high doses, NO
can also be toxic. In vivo, the detoxification of NO is achieved mainly through its reaction
with hemoglobin. [58, 113]. NO also reacts rapidly with oxygen to form nontoxic
compounds nitrate/nitrite[114]. SOD also regulates NO and the production of peroxynitrite
by scavenging superoxide[115].
1.2.1.3 Oxidative and nitrosative stress in diabetic foot ulcers
In the diabetic state, persistent hyperglycemia leads to an over production of superoxide by
activating different pathways; polyol pathway, xanthine and NADPH oxidases,
cyclooxygenases, uncoupled nitric oxide synthase, glucose auto-oxidation, mitochondrial
respiratory chain[57]. The result is high ROS levels and low antioxidants, a state defined
as oxidative stress. The high levels of superoxide surpasses the body’s antioxidant
mechanisms. Superoxide activates the NF-κβ transcription factor which upregulates
expression of NOS-2 and consequently NO production. In the presence of high superoxide
and low levels of the super oxide scavenger molecules, NO will react very rapidly with
superoxide to produce peroxynitrite consequently reducing the bioavailability of NO.
Moreover, high ROS and peroxynitrite levels in the hyperglycemic state limits the
production of BH4 (an indispensable co factor for NO production) and causes the
uncoupling of NOS to generate superoxide instead of NO [96, 116, 117]. The concentration
of arginase is another mechanism that interferes with NOS activity. Arginase competes
with NOS enzymes for the substrate arginine and reduces NO availability favoring
superoxide production. A diabetic induced state was found to increase arginase activity
levels in the wounds of diabetic mice and this correlated to delayed healing observed in the
study [35]. The deficiency of NO alters endothelial vascular function causing vessel
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constriction. Moreover, in diabetic patients with high cholesterol levels, the presence of
peroxynitrite favors lipid peroxidation and induces an inflammatory response, activating
platelet aggregation[96]. These effects are mostly pronounced in the small blood vessels
and plays a role in the progression of neuropathy[118]. Vascular impairment can result in
persistent ischemia. Wounds are often associated with low oxygen tension[119]. In
physiological conditions cells express HIF-1 α, a key transcription factor that allows the
cells to adopt to hypoxic conditions. HIF-1α promotes angiogenesis, cell proliferation, cell
survival and energy metabolism. NO is a key regulator in the expression of HIF-1α. The
effect of NO on regulation of HIF-1 α is very complex and yet indispensable to cell survival
and function under external insult. It is reported that the effect of NO on HIF-1 α is
primarily mediated by S-nitrosylation.[120]. In normoxia (1-10mmHg) and hypoxia, high
levels of NO (> 1µM) stabilize the HIF-1 α transcription factor while low NO levels (<400
nM) in hypoxia destabilize it[121]. During the early phases of wound healing when M1 are
predominant, it is possible that the high NO production from the cells facilitate the
stabilization of the protein in order to produce an adequate adoptive response to injury and
when this is resolved the low NO levels produced from the other cells promote resolution
in the wound environment to restore its normal state. In fact, Pena and O’Neil[122] report
a possible link of HIF-1α protein in the polarization of macrophages which might be
regulated by NO concentration. The association of ischemia in the presence of
hyperglycemia has devastating effects on the redox and metabolic state in the wound bed
by altering NO function and consequently adoptive response to the hypoxic environment.
Catrina et al showed that HIF-1 α protein levels were low in human endothelial and dermal
fibroblast cells cultured simultaneously in hyperglycemic and hypoxic conditions[123]. In
the same study, biopsy samples obtained from patients with DFU showed lower HIF-1 α
staining in the nucleus and cytoplasm compared to non-diabetic patients with chronic
wounds. Jazayeri et al [124] also showed increased expression of proapoptotic marker p53
as well as ischemia induced apoptosis in diabetic mice and dermal fibroblasts cultured in
hyperglycemic conditions. It is interesting that NO in a dose dependent manner also
regulates both HIF-1 and p53 expression. Thomas et al[90] showed that a single high
dose of NO (>2000 nM) increased the P53 P-Ser-15 protein levels while the same dose
delivered over a longer period of time increased HIF-1α protein levels instead. A
contrasting study showed inhibition of HIF-1  accumulation by NO in liver and cancer
cells (50 µM). However, addition of peroxynitrite scavengers alleviated this effect [125].
Patients with diabetes have been found to have high levels of nitrotyrosine in plasma[126].
Another study showed increased peroxynitrite production in diabetic platelets [115] and
other researchers have found high levels of nitrotyrosine levels in rat and mice diabetic
skin which correlated to the dysregulation in the wound healing process[127, 128].
The number of factors that affect wound healing are intertwined and very diverse. It is
further complicated in an altered metabolic and redox environment where the absence or
malfunction of one factor affects a cascade of events downstream. This is clearly
demonstrated in the key signaling molecule NO. The complexity of NO makes its
interpretation in vivo and invitro studies very sensitive to concentration, duration of NO
delivery and redox environment. These are all very important factors to consider in terms
of the response and efficiency to a given treatment plan for DFU.
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1.3 Current methods used to measure NO in diabetic conditions
and their limitations
The high reactivity and very short half-life of NO makes it extremely difficult to measure
directly under physiologically relevant conditions. As a result, the majority of studies in
the literature rely on its metabolic decomposition products nitrite/nitrate, enzyme activity
assays and protein levels. However, because of the complex chemistry of NO in an altered
cell or tissue environment, it is very difficult to interpret results from different studies and
draw a conclusion on the actual role of NO in a given pathology. In addition, the
decomposition of its toxic species such as peroxynitrite can also generate nitrite/nitrate in
vivo and invitro[112, 129]. It is therefore not surprising that NO studies in diabetic states
show contradicting results in the levels of NO determined as well as the outcome based on
these methods of analysis (Table 1-2).

Table 1-2. Experiments and analysis methods and outcomes on the effect of NO in
diabetic states
SAMPLE

SPECIES

NO
ANALYSIS

OUTCOME

MODEL

TREATMENT

REFERENCE

Aortic
endotheli
al cells

Human

Griess assay
(nitrite)

High nitrite
accumulation
,high
superoxide
levels,

High
glucose
22.2mm
ol/l

High glucose
22.2mmol/l

[130]

PCR
Western blot

High NOS-3
levels

Skin

Mouse

Immunofluo
rescent
staining,
PCR and
western blot

Low NOS-2
expression
and levels

Diabetes

Streptozotocin

[35]

Glomerul
ar
endotheli
al cells

Human

Griess assay
(nitrite)

Low nitrite
levels,
increased
NOS-3 levels

High
glucose
(15,30,6
0 mM)

High glucose
(15,30,60
mM)

[131]

Western blot
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Macroph
ages
(RAW
264.7 and
primary
peritoneal
macropha
ges)

Mouse

Skin
fibroblast
s

Human

Griess assay
(nitrite)

Umbilical
endotheli
al cells

Human

Skin

Griess assay
(nitrite)

High nitrite
levels,

High
glucose
(25mM)

LPS treatment

[132]

Western blot

Increased
NOS-2
expression
and levels

High nitrite
levels

High
glucose
(22.5/42
mM)

Irradiation 830
nm

[133]

Immunoblot
ting

Low
nitrosylation
NOS-3

High
glucose
(30mM)

High glucose
(30mM)

[134]

Mouse

NOS-3
deficiency
angiogenesis
assays

Delayed
wound
closure

NOS-3
knock
out

N/A

[135]

HUVEC

Human

Griess
assay, gene
expression

High nitrite
levels, high
NOS-2 AND
3

High
glucose
(100mM
)

High glucose
(100mM)

[136]

Blood
serum

Mouse

Griess assay

High nitrite
levels

Diabetes

Streptozotocin

[136]

Blood
serum

Human

Griess assay

High nitrite
levels

DM type
2

N/A

[136]

HUVEC

Human

Griess assay

Low nitrite
levels

High
glucose
(30mM

A23187
(2.5uM)

[137]

PCR

15

Skin

Mouse

Immunohist
ochemistry,
Griess assay

Low NOS-3
expression,
low nitrite
levels,
delayed
wound
closure

Diabetes

A23187
(2.5uM)

[137]

Skin

Mouse

Immunofluo
rescent
staining

High iNOS
expression,
delayed
wound
closure

Diabetes

Streptozotocin

[138]

Urine

Human

Griess assay
(nitrite)

Low nitrite
levels

DM
Type 2

Arginine
intravenous
infusion

[139]

In a diabetic mouse model, Miao et al found that M1 cells were deficient at the wound site
by staining for iNOS/cd68 macrophage marker. These cells mainly appeared early on in
the wound healing process and the levels of iNOS staining cells was low in diabetic mice
compared to controls. The low levels of iNOS were correlated to low NO levels and
delayed wound healing. The upregulation of the iNOS enzyme shows a causal relationship
with NO however it does not always translate to the actual levels of NO produced or how
it relates to cell function. For example, the islet cells in the pancreas stained positive for
nitrotyrosine an indicator of peroxynitrite destruction in another diabetic mouse model.
The formation of this protein was decreased in the presence of iNOS inhibitors or
superoxide scavengers[140]. In another study, high glucose increased NOS-3 expression
in vascular endothelial cells, although nitrite levels measured in the media was low. When
the superoxide scavenger SOD was added, nitrite levels were restored[131]. Another
indicator of this inconsistency is in Hwang’s study, the researchers looked at the effect of
high glucose on NO production in macrophage cells. The results showed that macrophages
produced more NO compared to cells cultured in normal glucose conditions and the NO
was reduced when an anti-inflammatory compound glucosamine was added[132]. The
nitrite accumulation in the media was taken as an indicator of NO production. In addition
to NO, macrophages also release significant amounts of superoxide which would greatly
have an effect on the bioavailability of NO released.
The majority of NO treatments in physiological cell culture conditions have shown a
positive effect on the function of cells involved in wound healing. For example, the NO
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donors sodium nitroprusside, Diethylenetriamine NONOate (DETANO) and S-nitroso-Nacetylpenicillamine (SNAP) in a dose dependent manner improved migration in
keratinocyte cells [141]. In other study, the migration and re-epithelialization of epidermal
stem cells was accelerated in the presence of NO donor SNAP[142]. Similarly, normal and
diabetic wound animal models have shown success which supports the theory that NO
levels are low in diabetic conditions and when integrated back into the system, these NO
levels are restored. (Table 1-3).

Table 1-3 The effects of NO treatments in vitro and in vivo experimental studies
MODEL

SPECIES/CELL
TYPE

TREATMENT

EFFECT

REFERENCES

Cell culture

Keratinocytes

SNP/DETANO/
SNAP, GSNO

Improved cell migration
and proliferation

[141, 143]

Cell culture

Fibroblasts

SNAP, NO
releasing
hydrogel and
particles

Improved cell
migration, proliferation,
ECM deposition

[143-145]

Cell culture

Epidermal stem
cells

SNAP

Improved cell migration
and re-epithelialization

[142]

Animal

Non-diabetic
mice

PCL/CSNO/NO
releasing
ointment

Re-epithelialization,
improved granulation
tissue,collagen
deposition and
angiogenesis

[146, 147]

Animal

Diabetic mice

NO releasing
hydrogel and
nanoparticles

Reduced inflammation,
increased collagen
deposition, angionesis
and granulation tissue

[144, 148]

S-Nitrosoglutathione (GSNO), polycaprolactone (PCL), chitosan-based NO-releasing biomaterials
(CS-NO)

However, the translation of NO treatments in patients affected with DFU has yielded
insufficient results despite the fact that most of these clinical trials were completed (Table
1-4).
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Table 1-4 Reports on clinical trials that applied NO treatments to patients with DFU
STUDY

REGISTR
ATION #

STATUS

OUTCOME

Advanced plasma
therapy 001plasma/NO
therapy for the treatment
of diabetic foot ulcers

NCT0307
8933

Recruiting (2017)

Nitric Oxide Generating
Gel Dressing in Patients
with Diabetic Foot Ulcers
(ProNOx1)

NCT0198
2565

Completed (2016)

Reduced wound
size, improved
healing and
minimal adverse
effects

[149]

PT001 Plasma/NO
Generator to Treat
Diabetic Foot Ulcer in
Adults (APT-14-002

NCT0235
6835

Completed (2016)

No results
posted

https://clinicaltrials
.gov

Electrical Stimulation
and Expression of VEGF
and NO in Diabetic Foot
Ulcer

NCT0201
9082

Completed (2013)

No results
posted

https://clinicaltrials
.gov

Clinical Trial for the
Treatment of Diabetic
Foot Ulcers Using a
Nitric Oxide Releasing
Patch: PATHON

NCT0042
8727

Completed (2012)

No results
posted

[150]

N/A

REFERENCES
https://clinicaltrials
.gov

This shows the problem of relying only on biproducts or enzyme activity to dictate NO
function. The assumption in the Griess assay is that all the NO produced is converted to
nitrite in the presence of an enzyme nitrate reductase. This method is not quantitatively
accurate and is susceptible to variations depending on the media or buffer used[151]. The
sensitivity of the assay is also quite low with a detection limit of approximately (0.10.5µM). With NOS activity, it is inferred that the presence of the NOS enzyme represents
NO levels and function which is also grossly inaccurate since the enzyme can uncouple to
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generate other reactive oxygen species [116]. Most importantly, they are all accumulation
assays and the means of determining the rate of production of NO or how this rate changes
over time in different pathological states is practically impossible. He and Frost[152]
developed a novel measurement system (the CellNO trap) that allows the direct, real-time,
continuous measurement of NO produced or exposed to cells under conventional culturing
conditions using chemiluminescence, one of the most sensitive and specific methods for
detecting NO through its reaction with ozone[74]. This device has previously been
validated and used to characterize the rate and amount of NO produced in macrophage cells
as well as the actual levels of NO that cells are exposed to when treated with soluble NO
donors[153]. The authors proved that the average or maximum NO measured is not an
indicator of the dynamic character of NO. In addition, they showed how adding of different
NO mediators commonly used in the literature affects the NO release in real-time. For
example, adding arginine, the NO substrate that is frequently used to increase NO
production in various studies had different effects on the NO release profile in stimulated
macrophage cells depending on the time that it was added. The results from the same study
also showed that the Griess assay recorded significantly lower NO levels compared to the
real-time NO measured. He and Frost [153] further demonstrated that various conditions
such as the pH, CO2, reaction volume and redox environment affect the ultimate NO levels
that cells in culture are exposed to. The soluble NO donor DETANO at different pH levels
in the presence and absence of CO2 showed different NO release profiles. At physiological
pH, there was an increase in NO release which stayed constant for 24 hours. In the presence
of CO2, there was higher peak of NO which gradually reduced over 24 hours and at pH 6
the NO level had the highest peak but by 15 hours the NO treatment was depleted [153].
In a study, that included 50 patients with chronic and acute wounds, the baseline pH levels
of most wounds was approximately 8.5[154]. The evidence that the NO release from NO
donors alters with changes in pH further proves that without the knowledge of the dynamic
changes in the NO released from NO donors, the outcome of these treatments is
unpredictable. Moreover, the soluble NO donor SNAP showed large variation in its NO
release profile for different replicates measured[153]. Three studies (Table 1-3) showed
that both SNAP and DETANO accelerated migration, improved proliferation and re
epithelialization of keratinocytes, epidermal stem cells and fibroblasts in invitro wound
healing models. However, the NO release kinetics of these two NO donors were not
determined. The authors relied only on the overall analytical concentration of the NO
donors which might prove to be a challenge in reproducing these effects in NO treatments
for DFU. On the bright side, two clinical studies have shown promising results. In patients
with diabetic neuropathy, isosorbide dinitrate alleviated pain but did not show an effect in
improving other sensory symptoms[155]. The use of this organic nitrate compound has
been very successful in patients with heart failure when administered with an
antioxidant[156] which might equally show better results for diabetic patients with
peripheral vascular disease if the same mode of administration is employed. The second
study was in a randomized clinical trial in which patients were given an NO release wound
dressing sustained for 12 weeks. There was significant reduction in wound area, improved
healing and minimal adverse effects compared to patients treated with standard wound
dressings. The study was also superior to others because they included patients with
ischemic and infected ulcers. While it showed a positive response in wound healing, the
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absolute effects of NO could not be measured and the NO levels at the wound site of the
patients was also unknown[149] [157].

1.4 Statement of purpose
Brüne and Zhou used an interesting analogy to define the role of NO and hypoxia. They
described this relationship as one ranging from courting to matrimony and divorce[121].
In essence this same analogy can be used to describe the overall NO function in the
physiological wound healing process and its alteration in DFU. Wound healing is very
dynamic and complex with different yet overlapping stages that are controlled from the
molecular to the cellular and tissue level. It’s clear that NO is needed in each of these
stages. However, the timing, dose and duration of NO produced is very distinct and its
function at a given time relies greatly on the redox environment. This harmony is severely
altered in an unstable metabolic state like diabetes and consequently it plays a major role
in the improper and delayed healing of DFU. Therefore, understanding how the direct NO
levels produced from the cells actively involved in healing changes over time in both
physiological and pathological conditions is extremely critical in developing NO
treatments to reestablish skin integrity. The work herein mainly focuses on using the device
that was previously developed to determine the real- time NO levels produced from cells
involved in wound healing under physiological and diabetic conditions. Chapter 2 shows
the real- time NO produced from normal human skin fibroblasts cultured in normal glucose
conditions and how the levels of NO change in high glucose conditions in the presence and
absence of inflammatory mediators. This study reports the first ever assessment of realtime NO produced from human dermal fibroblast cells. Chapter 3 adopts these culture
conditions to determine the real- time NO produced in human wound dermal fibroblast
cells isolated from a patient with a chronic ulcer. In addition, a highly sensitive method of
analysis is validated to determine the nitrite and nitrate levels present in wound fluid
obtained from patients with chronic ulcers. Chapter 4 reports the changes in NO levels
produced from the macrophage cell line RAW 264.7 cultured in normal and high glucose
conditions and finally chapter 5 looks at the potential applications of real-time NO
measurements in localized NO delivery systems and in the determination of the role of NO
in the progress of cardiovascular calcification.
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2 INVESTIGATIVE STUDY OF REAL-TIME NO
MEASUREMENTS IN NORMAL FIBROBLAST CELLS
IN NORMAL AND HIGH GLUCOSE CONDITIONS1
Fibroblasts are the most prevalent cell type in the dermis layer of the skin. The main
function of fibroblasts is to secrete the extracellular matrix (ECM) scaffold, for all cells
residing in the skin tissue [158]. They are the most important mesenchymal cells and are
defined as the architects of the wound healing process. The main component of the ECM
is collagen which replaces the fibrin provisional matrix. Other elements include
proteoglycans, glycoaminoglycans (GAGS), heparin sulfate and elastin that facilitate the
aggregation of collagen fibrils, direct cells, cytokines and growth factors within the ECM
as well as providing flexibility to the skin [159]. Fibroblasts also regulate the growth and
function of other cells involved in wound healing through the production of growth factors
and secretion of MMPS. Table 2-1 shows the components produced by fibroblasts and
their roles during healing. A few studies have emerged that provide evidence of NO
production from fibroblast cells. Wang et al showed that human skin fibroblasts produced
low levels of NO and express both constitutive and inducible forms of NOS[43]. The NO
produced was hypothesized to be involved in the inflammatory process before the arrival
of the immune cells. In a follow up study that consisted of cells isolated from hypertrophic
burn tissue and site marked normal skin tissue, NO levels, enzyme activity and expression
were reduced in cells isolated from hypertrophic scar tissue compared to normal skin tissue.
The authors drew the conclusion that NO helps to control the proliferation of cells and its
deficiency was evidence to explain hypertrophic scar formation in patients. During the
same period, Schaffer et al also showed NO production from mouse wound dermal
fibroblasts played a role in collagen deposition and wound mechanical strength. In the same
study, the group demonstrated that wound fibroblast cells produce NO while normal
fibroblasts do not produce NO. Furthermore, the NO levels were reduced in subsequent
cell passages. Other authors have reported increased NO production from human skin
fibroblasts when irradiated with UV light and showing potential in regulating the
proliferation of the cells[160]. The NO production in fibroblasts is altered in diabetes. In
Schaffer et al’s study,[161] the wound breaking strength and collagen deposition was low
in wounded diabetic induced mice compared to normal mice and this correlated with the
low nitrite levels in the wound fluid and cells isolated from these wounds. Another group
of researchers showed that the NO production was low in fibroblast cells cultured in
diabetic conditions and it was significantly increased when the cells were irradiated with a
light source. Moreover, cell migration and proliferation in diabetic conditions was
improved when the cells were irradiated with light[162]. It’s interesting that none of these
studies looked at the direct NO levels or how the production of NO would change or alter
the effect observed depending on the culture conditions. The researchers only looked at
The majority of the work presented in this chapter was submitted and published in Medical Sciences and
the rights to use this content is presented in appendix C and licensed under Creative Commons Attribution
4.0 International License
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nitrite or enzyme activity to correlate the function and production of NO in fibroblast cells
which might not be an accurate assessment.

Table 2-1 Elements produced by fibroblasts and their function in wound healing
Elements

Function

Collagen, proteoglycans, hyaluronic
acid, tropoelastin and elastin

Strength, cell movement,
aggregation of collagen
fibrils, direct and regulate
function of cells and growth
factors,
resilience
and
elasticity

[26, 158, 163]

Cytokines (IL-1, IFN-γ, TNF-α)

Stimulate production of
growth factors, regulate
inflammatory response

[26, 163]

Cysteine-rich
61(Cyr61)

inducer

Regulate
inflammation,
angiogenesis,cell
matrix
interaction,
matrix
remodeling

[164-167]

(NGF,

Nerve growth, keratinocyte
proliferation, angiogenesis,
cell proliferation, chemotaxis

[26, 163, 168]

ECM remodeling, activation
and regulation of growth
factors

[26, 66]

angiogenic

Growth factors
TGF-β, PDGF, FGF.EGF)

MMPS and TIMPS

References

In this chapter, we specifically elucidated the temporal aspects (both rate and amount) of
NO produced by human dermal fibroblasts under normal glucose (5.5mM) and high
glucose (25mM) conditions. For the first time, we report the actual levels of NO that human
dermal fibroblast cells produced in real-time both with and without stimulation. The rate
of cell proliferation and the expression of the iNOS enzyme responsible for the production
of NO when the cells are stimulated by inflammatory cytokines was also assessed. The
real- time NO and nitrite accumulation were measured in the cells and cell culture media,
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respectively, and compared. By understanding the levels of NO produced and how it
compares to the nitrite and the protein expression in these cells under both normal and
diabetic conditions, we will begin to clearly understand the levels and timing of NO
delivery necessary to promote appropriate fibroblast proliferation, migration and
deposition of the extracellular matrix in order to reduce the healing time in chronic DFUs.

2.1 Materials and Methods
2.1.1 Cell culture and chemical supplies
Primary human adult dermal fibroblasts (HDFa, ATCC® PCS-201-012™,), mouse
macrophages (RAW 264.7), penicillin streptomycin, fetal bovine serum (FBS), phosphate
buffered saline (PBS), MTT proliferation assay kit and Dulbecco’s modified eagle medium
(DMEM high glucose 4500mg/l) were all purchased from ATCC (Manassas, VA). DMEM
(no glucose), sodium pyruvate and Hoescht dye were obtained from Fischersci (Hanover
Park, IL). D-(+)-Glucose, Lipopolysaccharide pseudomonas aeroguinosa (LPS), CalceinAM, protease inhibitor cocktail, mouse nitric oxide synthase and dopamine-HCl were
purchased from Sigma-Aldrich (St. Louis, MO). Ethidium bromide was acquired from
Invitrogen (Grand Island, NY). Human recombinant Interferon gamma (hrIFN-Ƴ) was
purchased from GenScript (Piscataway, NJ). The primary and secondary antibodies against
CD90/Thy1 (ab23894) protein and inducible nitric oxide synthase (iNOS) (ab136918)
were purchased from Abcam (Cambridge, MA). The 7.5% SDS polyacrylamide gels and
gelatin were acquired from Bio-Rad (Hercules, CA). The Odyssey western blot starter kit
2 was obtained from LI-COR (Lincoln, NE). Silicone elastomer base and curing agent
(Dow Corning Sylgard®184) were obtained from ML Solar LLC (Campbell, California).

2.1.2

Real time NO measurements from Primary human adult dermal
fibroblasts

Primary adult dermal fibroblasts at passage 1 were cultured and expanded in conventional
cell culture plates (100mm) in DMEM (high or normal glucose levels), 10% FBS and 1 %
penicillin/streptomycin (complete growth media). At confluency, the cells were reseeded
in CellNO trap devices at a density of 0.25-1 ×104 cells/cm2. Previously, we have reported
the detailed fabrication and characterization of the device [152]. Briefly, silicone elastomer
base and curing agent were dissolved in hexanes, manually cast onto 5×5 square
polyvinylidene fluoride (PVDF) membranes and left to cure in a 50⁰C oven for 24 hours.
The modified membrane was cut into a circle to fit into a 60mm diameter cell culture plate
with the bottom removed forming the upper chamber. The upper chamber was sealed by
applying toluene to the edges of the membrane and the plate. A second 60mm plate with
drilled holes and plastic outlets attached was affixed to the upper chamber using toluene
and reinforced with epoxy adhesive. The upper chamber was used for cell culture and the
lower chamber was used for gaseous transfer. To make the device suitable for cell culture,
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freshly prepared dopamine solution in Tris-HCl buffer (2mg/ml) was added to the device
and incubated for 12 hours. The device was rinsed several times and sterilized using 70%
ethanol and ultraviolet light (1 hour). Prior to cell culture, the device was coated with
gelatin solution (2mg/ml). After 24-72 hours, the cell culture media was changed and
substituted with media containing 40µg/ml of LPS and 200 U/ml of hrIFN-Ƴ or complete
growth media (control) under normal glucose (5.5mM) and high glucose (25mM)
conditions. The device was placed in a standard incubator (37°C, 65% humidity, 5% CO2)
and was connected to a calibrated nitric oxide analyzer (NOA) and the real-time NO release
profile was measured for 24 hours.

2.1.3

Cell viability assay in the CellNO trap device

After 24 hours, the live-dead assay was carried out using 2µM calcein AM, 2µg/ml
ethidium bromide and 10µg/ml Hoescht dye in DMEM media for 10-15 minutes. The cells
were imaged and analyzed using an Olympus fluorescent microscope (model BX51) and
Image J1 respectively[169].

2.1.4

Cell proliferation assays (MTT assay)

The fibroblast cells were cultured in 96 well plates at a density of 10,000 cells per well in
normal and high glucose cell culture conditions and stimulated with 40µg/ml and 200U/ml
of LPS and IFN respectively. At the end of 24, 48 and 72 hours, MTT assay was performed
according to the manufacturer’s instructions (Trevigen, 4890-025-K) with minor
modifications. Briefly, the cell culture media was replaced with 25µl of the MTT reagent
and incubated for 4 hours to allow the intracellular reduction of soluble yellow MTT to
insoluble formazan dye. The MTT reagent was discarded and 100µl of Isopropyl alcohol
was added to solubilize the dye. The absorbance was read at a wave length of 570nm using
a Beckman Coulter microplate reader model DTX880.

2.1.5

Nitrite assay

After 24 hours of measurement in the CellNO trap device, the cell culture media from the
cell samples under normal and high glucose conditions were collected. The triiodide assay
was used to measure the nitrite accumulation in the media[74]. Briefly, 50µl of the media
was added to a vial containing a stirring solution of 300µl of glacial acetic acid and 120µl
of potassium iodide. The vial was connected to a calibrated Sievers Nitric Oxide Analyzer
280i (Zysense, LLC, Boulder, CO, USA) and the NO produced from the nitrite present in
the media was measured and normalized to the number of live cells.
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2.1.6

Cell characterization

Fibroblast cells at passage 2 were cultured in 12 well plates at a cell density of 1 ×104/cm2
in normal and high glucose conditions. At confluency, the cells were fixed in 4%
paraformaldehyde for 10 minutes, rinsed 3 times in phosphate buffered saline, incubated
in blocking buffer for 90 minutes followed by the primary antibody for 18 hours at 4°C.
The cells were rinsed 3 times in blocking buffer and incubated for 1 hour at room
temperature with the secondary antibody, stained with 4', 6-diamidino-2-phenylindole
(DAPI) and viewed under a fluorescent microscope.
2.1.7

Western blot analysis

Confluent HDFa cells were cultured in 100mm diameter tissue culture dishes, stimulated
with 40µg/ml of LPS and 200U/ml IFN-Ƴ in normal and high glucose conditions and
incubated for 72 hours. Mouse macrophage cells RAW 264.7 were grown to confluency
and stimulated with 100ng/ml of LPS for 18 hours and served as the positive control. The
cells were quickly washed in ice cold PBS, trypsinized, centrifuged and re-suspended in
200µl of RIPA buffer in the presence of protease cocktail inhibitors. The cell lysates were
incubated for 30 minutes on ice on a plate shaker and centrifuged at 12,000 rpm for 20
minutes at 4°C. The supernatant was collected, and the protein concentration determined
for each sample using Bradford assay[170]. An equal amount of loading buffer containing
dithiothreitol was added to each sample, boiled at 100°C for 5 mins and immediately placed
on ice for 2 mins. About 5.63-9.37µg of protein was loaded in a 7.5% SDS-PAGE gel and
separated by electrophoresis at 100V for approximately 70 minutes. The proteins were
transferred to immobilon®-FL PVDF membrane using the Trans-Blot® Turbo™ Transfer
System (Bio-Rad) for 7 minutes. The membrane was incubated in Odyssey blocking buffer
(TBS) for 60 minutes to block nonspecific binding sites followed by incubation in TBS
containing 0.2% of tween20 (TBS-T) and the iNOS antibody (1:1000 dilution) for 18 hours
at 4°C. After that, the membrane was washed 4 times with TBS (0.1% tween20) and
incubated in TBS-T with the secondary antibody (1:20000 dilution) for 1 hour then
extensively washed in TBS, visualized by LI-COR Odyssey infrared imager and analyzed
using Image Studio Lite Software Version 5.2.
Statistical analysis was performed in Microsoft Excel using one-way ANOVA followed by
a benferroni corrected t-test with statistical significance set at a 95% confidence level
(P<0.05).
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2.2 Results
2.2.1 Real-time NO detected under normal and high glucose conditions
HDFa were cultured in the CellNO trap in either normal (5.5mM) or high glucose (25mM)
media with and without stimulation by the inflammatory cytokine interferon gamma (IFNƳ) and bacterial endotoxin lipolysaccharide (LPS). The NO production was measured for
24 hours (Figure 2-1)[42].

Figure 2-1. The real-time NO release from HDFa with (+) and without (-)
stimulation cultured under normal (5.5mM) and high glucose (25mM) conditions.
Arrow represents calibration of NOA. Image copied from [42]. The right to use this
material is licensed under Creative Commons Attribution 4.0 International License.

The cells cultured in normal glucose media in the absence of stimulation showed a slight
increase in NO release in the first 1 hour which peaked at 0.25×10-12 moles/min.cm2 and
gradually went down to undetectable NO production up to 24 hours. HDFa cultured in high
glucose media without stimulation showed an increase in NO production which peaked at
0.56×10-12 moles/min.cm2 and remained constant for 24 hours. With stimulation, there was
an increase in the NO production for cells cultured in normal glucose media, which peaked
at 2.03×10-12 moles/min.cm2 and gradually dropped to 0.76×10-12 moles/min.cm2. At 12
hours, the NOA was disconnected and recalibrated to confirm the validity of the signal
obtained (Arrow denoting the sudden drop in curve in Figure 1). The NO detected remained
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constant at 0.44×10-12 moles/min.cm2 from 15 to 24 hours. The NO release for cells
cultured in high glucose media followed a similar trend but with lower NO detected, which
peaked at 0.93×10-12 moles/min.cm2 at 5 hours and gradually dropped to 0.23×10-12
moles/min.cm2 at the end of 24 hours. The viability of the cells cultured in the CellNO trap
device in normal and high glucose culture conditions with and without stimulation by IFNƳ and LPS was analyzed by the live/dead assay at the end of the real-time NO
measurements. The cells maintained over 95% cell viability in all the treatment groups
(Figure 2-2).

Figure 2-2. Cell viability detected by calcein AM and ethidium bromide for HDFa
cultured in normal (5.5mM) glucose condition without and with stimulation, A and
B respectively and high glucose (25mM) condition without and with stimulation C
and D respectively. Scale bar 500µm. The results are presented as the mean ±
standard deviation for n=3, *p<0.05. Image copied from [42]. The right to use this
material is licensed under Creative Commons Attribution 4.0 International License.

2.2.2

Nitric oxide detected from nitrite accumulation in the absence and
presence of stimulation

After the real-time NO measurements, the nitrite accumulated in the cell culture media was
collected and analyzed for NO release using the triiodide assay (Figure 2-3). The nitrite
present in the media is reduced in the presence of an acid and nucleophile to produce NO
that is measured via chemiluminescence detection.25 Normal glucose conditions without
stimulation had significantly lower NO levels produced from nitrite compared to normal
glucose conditions with stimulation (0.73±0.05 versus 3.68±0.98 nmol/105 cells, p<0.05
for n=3). In high glucose conditions, there was no statistical difference in the levels of NO
detected without stimulation compared to stimulation with LPS/IFN (0.91±0.70 versus
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4.26±2.11 nmol/105 cells). In the absence of stimulation, the NO detected from nitrite in
normal glucose conditions compared to high glucose were not significantly different
(0.73±0.05 vs 0.91±0.70 nmol/105 cells). Similarly, with stimulation, the NO detected from
nitrite was not statistically different in normal glucose compared to high glucose
(3.68±0.98 vs 4.26±2.11 nmol/105 cells).

Figure 2-3, Total NO compared to nitrite accumulation determined for HDFa
with and without stimulation under normal and high glucose conditions. (for
n=3, there is statistically significant difference at p<0.05: * Normal glucose
(LPS/IFN) vs Normal glucose (without stimulation); $ Normal glucose
(LPS/IFN) vs High glucose (LPS/IFN). Image copied from [42]. The right to
use this material is licensed under Creative Commons Attribution 4.0
International License.

2.2.3

Comparison of real-time NO measurements and nitrite accumulation

The total NO detected in real-time for the HDFa was integrated as the area under the curve
(Figure 2-3) and was compared to the NO inferred from nitrite present in the cell culture
media for the 4 treatments groups (Figure 3, N=3). lists the total amount of NO and nitrite
produced by each test group. The results showed that the levels of real-time NO detected
in nmol/105 was significantly higher for cells in normal glucose conditions with stimulation
(8.42±1.16 p<0.05 for n=3) compared to without stimulation (0.48±0.31 for n=3 p<0.05).
Similarly, under identical conditions, nitrite accumulation was significantly higher in
normal glucose with stimulation (3.68±0.98) compared to absence of stimulation
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(0.73±0.05 for n=3 p<0.05). It is interesting to note that there was a higher direct NO
measured compared to nitrite. However, high glucose conditions did not show the same
trend. The levels of real-time NO detected with stimulation were not statistically different
from levels of real-time NO without stimulation (3.26±0.79 and 2.85±0.91 nmol/105cells
respectively). The NO levels obtained from nitrite measurement depicted a similar trend as
the real-time NO measured, with no statistical difference in high glucose conditions with
stimulation compared to high glucose without stimulation (4.26±2.11 and 0.91±0.70
nmol/105 cells). The real-time levels of NO and nitrite detected in normal glucose
conditions without stimulation was also not statistically different from the real time NO
detected from the cells in high glucose conditions without stimulation (0.48±0.31 and
3.26±0.79 vs 0.73±0.05 and 0.91±0.70 nmol/105cells respectively for n=3 p<0.05).
Moreover, in normal glucose conditions with stimulation, the levels of real-time NO
detected was significantly higher compared to high glucose conditions with stimulation.
The nitrite levels were not statistically different. (8.42±1.16 and 3.26±0.79 versus
3.68±0.98 and 4.26±2.11 nmol/105cells respectively).

2.2.4

Cell characterization of HDFa cultured in normal and high glucose
conditions

HDFa cultured in normal and high glucose media were assessed for the presence of CD90
(Thy-1), which is a reliable molecular marker used to identify fibroblast cells in
culture[171]. HDFa maintained uniform staining for CD90 (Thy-1) protein in normal
(Figure 2-4a) and high glucose conditions (Figure 2-4b) as well as the elongated and
spindle shape that is characteristic of confluent fibroblast cells.

Figure 2-4. Immunofluorescent staining of CD90 (Thy-1) (green) in HDFa
cultured in (A) Normal and (B) High glucose conditions. Cell nuclei (blue).
Scale bar 200µm. Image copied from [42]. The right to use this material is
licensed under Creative Commons Attribution 4.0 International License.
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2.2.5

Expression of iNOS protein in HDFa cultured in normal and high
glucose conditions

Stimulation of fibroblasts by inflammatory cytokines and bacterial endotoxins has been
reported to upregulate the enzyme iNOS, which is directly responsible for the production
of NO in the cells. We assessed the levels of iNOS in HDFa cultured in normal and high
glucose conditions with and without stimulation by western blot technique. The results
show that overall the iNOS enzyme was present in all treatment groups and the protein
level was very low. Macrophage cell lysates (RAW 264.7) that are known to express iNOS
when stimulated with LPS and the mouse iNOS enzyme protein were used as positive
controls. Faint iNOS bands can be seen in the human fibroblast cells, which appear at the
same molecular weight as the iNOS in macrophage cells and the mouse iNOS enzyme
(Figure 2-5). There was no statistical difference in intensity found between the groups at
P<0.05 for n=3.

Figure 2-5. Detection of iNOS expression by western blot analysis of HDFa
cultured in normal (NG) and high glucose (HG) conditions with (+) and without
(-) stimulation. Predicted band size for iNOS 131 kD and observed band size
125kD with iNOS and RAW 264.7 (M+) as positive controls. Image copied from
[42]. The right to use this material is licensed under Creative Commons
Attribution 4.0 International License.
2.2.6

Effect of normal and high glucose conditions with and without
stimulation on the proliferation of HDFa cells.

The proliferation rate of HDFa cells cultured in normal and high glucose conditions with
and without stimulation by IFN-Ƴ and LPS was assessed by the MTT proliferation assay
for 24 to 72 hours. The cells that are metabolically active reduce the tetrazolium salts in
the MTT reagent to intracellular purple formazan crystals, which when solubilized can be
read at an absorbance of 570nm and correlated to the proliferation of the cells[172]. In
normal glucose conditions in the absence and presence of stimulation there was an increase
in cell proliferation from 24 to 72 hours (0.08 to 0.14 and 0.08 to 0.12 respectively). High
glucose conditions with no stimulation showed a slight drop in absorbance from 24 to 48
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hours (0.07 to 0.06) and an increase to 0.15 at 72 hours. High glucose conditions with
stimulation also showed an increase in absorbance; 0.06 at 24 hours to 0.09 at 72 hours.
Overall, there was no statistical difference between the treatment groups at 24, 48 and 72
hours (n=3 P<0.05 (Figure 2-6)2

Figure 2-6. The rate of proliferation observed in HDFa cultured in normal (5.5
mM) and high glucose (25mM) conditions with (+) and without (-) stimulation
from 24 to 72 hours. Three independent experiments were performed in
triplicates (n=3). P value <0.05 was considered statistically significant. Image
adopted from [42]. The right to use this material is licensed under Creative
Commons Attribution 4.0 International License.

2.3 Discussion
Diabetic foot ulcers remain an immense challenge with debilitating consequences and no
adequate treatment. One of the major problems in the delayed healing of these wounds is
the senescent nature of fibroblasts and their inability to proliferate and produce
extracellular matrix that will aid in the migration of keratinocytes across the wound bed
[18, 19, 168, 173, 174]. NO is widely implicated as a major player in the wound healing
process and studies have shown that fibroblast cells produce NO [43, 44, 175, 176].
Whether or not this NO production is consistent even in the absence of stimulation is still
a matter of debate. Moreover, the spatial and temporal NO production and levels that
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fibroblast cells experience is not known. The Griess assay used by previous authors only
looks at the accumulated NO release at single point in time and this method of analysis
measures nitrite, the stable end product of NO, not NO itself. The availability of NO to
regulate biological functions greatly relies on various factors such as the dose, duration,
location of NO production as well as the surrounding environment [90, 177, 178].
Therefore, the presence of nitrite in the cell culture media might not automatically translate
to the level of NO generated and therefore cast doubt on the causal relationship NO may
or may not actually have in the physiological environment [177, 178]. Wound healing is a
dynamic process and understanding how the levels of NO production in the cells at the
wound site changes over time is of utmost importance in exploring the possible use of NO
to treat DFUs.
We recorded the real-time production of NO from fibroblast cells under normal and high
glucose conditions with and without stimulation by the bacterial endotoxin LPS and
inflammatory cytokine IFN-Ƴ. The results obtained were then compared to the nitrite
accumulation in the cell culture media. HDFa cells in normal glucose conditions with
stimulation showed that significantly higher NO was detected compared to HDFa cultured
in normal glucose conditions without stimulation (8.42±1.16 vs 0.48±0.31 nmol/105cells,
p<0.05 for n=3). Stimulation by LPS and IFN-Ƴ is thought to upregulate the expression of
iNOS and consequently NO production in a variety of cells including human and rodent
fibroblasts[43, 179]. In cells such as macrophages, the production of NO acts as a host
defense mechanism to fight off infection [29, 176]. In the normal wound healing process,
the production of NO in fibroblast cells could act to regulate the inflammatory response at
the wound site[43]. Alternatively, and/or additionally the production of NO could be
associated with regulation of cell proliferation, collagen deposition or angiogenesis, which
would show its possible role in the proliferation stage [43, 44, 176]. The NO detected from
the cells cultured in high glucose media with stimulation was not significantly different
from the NO detected in non-stimulated cells cultured in the same media. Interestingly,
cells cultured in normal glucose conditions in the absence of stimulation showed barely
detectable levels of NO while NO levels in high glucose conditions without stimulation
was significantly higher (Figure 2-1 and 2-3). Schaffer et al. showed that fibroblast cells
do not produce NO unless they are phenotypically altered to produce NO (wound
fibroblasts)[44]. However, Wang et al showed that fibroblast cells spontaneously produce
NO even in the absence of stimulation[43]. The levels of glucose used in the cell culture
media were not specified in Wang’s study. High glucose DMEM media that is routinely
used in culture of a variety of mammalian cells contains 25mM of glucose, which is four
times greater than clinically relevant glucose levels (5.5-7mM)[4]. Therefore, the levels of
glucose in the cell culture media could possibly explain the discrepancy reported in the
literature. Cells cultured in normal glucose conditions with stimulation had significantly
higher levels of NO detected compared to stimulated cells cultured in high glucose
conditions (Figure 2-3). Low levels of NO and reduced nitric oxide synthase levels in the
diabetic state has been strongly associated with the development of DFU and impaired
wound healing [85, 133, 180]. Schaffer et al found that low NO levels correlated with
reduced collagen deposition and wound strength in wounded diabetic mice compared to
healthy mice[44]. The mechanism of low NO levels in the diabetic state is still unclear but
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evidence points toward the increased production of reactive oxygen species, such as
superoxide, that rapidly inactivate NO, reducing its bioavailability in the cells[176, 178].
It is worthwhile to note that all of these studies only looked at nitrite accumulated in the
cell culture media and not NO levels directly exposed to the surface of the cells. Our work
has shown that the NO and nitrite levels are different under normal and high glucose
conditions and the variability is further compounded when stimulated by NO inducing
factors such as LPS and IFN-Ƴ. The real-time NO measurements were compared to the
nitrite accumulated in the cell culture media. The levels of real-time NO in normal glucose
conditions directly correlated with the nitrite levels in the presence and absence of
stimulation. However, high glucose conditions showed a discrepancy in real-time NO and
nitrite levels detected (in both cases, the results were not statistically different, but the
difference observed suggests further study is warranted). Human aortic endothelial cells
cultured in high glucose media has been shown to have higher levels of nitrite compared
to cells cultured in normal glucose conditions in the absence of stimulation[181]. In another
study, nitrite levels were suppressed in human renal endothelial and mouse schwan cells
cultured in high glucose media compared to normal glucose media[131, 182]. The
contradicting results obtained from these studies further illustrates that measuring only
nitrite in the media is not sufficient to assess actual NO production and thereby attribute
specific effects of NO on different cellular processes especially under a pathological state
such as diabetes.
The iNOS enzyme is thought to be upregulated when cells are stimulated by inflammatory
mediators. We analyzed the expression of iNOS in fibroblast cells in normal and high
glucose levels with and without stimulation by LPS AND IFN-Ƴ. The iNOS enzyme was
found in both normal and high glucose conditions in the absence and presence of
stimulation. Although, the expression was very low with no statistical difference between
the 4 treatment groups. Fibroblast cells produce low amounts of NO, which could explain
why the enzyme expression in the cells was low. To support this view, Wang showed that
with immunocytochemical staining, only few stimulated fibroblast cells stained intensely
for iNOS, while majority of the cells showed weak staining. Some unstimulated fibroblast
cells also showed weak expression of iNOS. Interestingly, histological staining on the
dermal tissue was negative for iNOS[43]. There are various factors in the cell culture
system that could potentially affect cell response. An example of rat hepatocytes was
reported by Halliwell; Isolation of the cells from the tissue was found to activate iNOS in
the absence of stimulation. The author also reported that the oxygen levels in in vitro cell
culture systems (150mmHg) was found to be much higher than the physiological levels of
oxygen that the cells are exposed to in vivo (1-10mmHg)[183]. These high levels of oxygen
are associated with increased production of reactive oxygen species (ROS). Reactive
oxygen species activate the Nuclear factor-kappa B (NF-KB) signaling pathway that leads
to transcription of iNOS mRNA and increased expression of the iNOS enzyme[184].
Moreover, ROS such as superoxide rapidly react with NO forming peroxynitrite. The NO
deficiency in the cell environment is hypothesized to activate a feedback mechanism that
upregulates iNOS expression[185]. In regards to these findings, we speculate that other
factors including the levels of glucose present in the cell culture environment might explain
the differences of nitrite levels compared to the real-time levels of NO observed.
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Nitric oxide has been shown to regulate the proliferation of cells and production of
extracellular matrix[186, 187]. In the diabetic wound, fibroblast cells do not proliferate
adequately and there is reduced secretion of extracellular matrix, which is a key component
for the migration and differentiation of keratinocyte cells [18, 19, 31]. Xuan et al have
explored the effect of high glucose on human foreskin fibroblast proliferation with no
significant difference at up to 60mM of glucose concentration (media supplemented with
10% FBS)[188]. In Schaffer’s study inhibition of endogenous iNOS production in mouse
wound fibroblasts did not affect proliferation[44]. While Shi et al showed reduced
proliferation of dermal fibroblast cells isolated from iNOS knock out mice compared to
wild type mice[189]. The correlation between glucose levels in the presence of
inflammatory mediators that stimulate NO production and its effect on human dermal
fibroblast cell proliferation has not been previously reported. We looked at the effect of
normal and high glucose conditions with and without stimulation of NO production on the
proliferation of fibroblast cells. The results show that overall there was no statistical
difference between normal and high glucose conditions in the absence and presence of
stimulation from 24 to 72 hours (Figure 6). However, the proliferation was lower in high
glucose condition with stimulation at 48 and 72 hours compared to normal glucose with
and without stimulation at the same time points, which prompts further investigation.

2.4 Conclusion
Our study showed that human dermal fibroblast cells cultured in normal glucose conditions
with stimulation show significantly higher levels of NO compared to cells cultured in high
glucose conditions with stimulation (8.42±1.16 and 3.26±0.79 nmols/105 cells p<0.05 for
n=3). The nitrite levels in normal glucose conditions showed consistency with the real-time
NO levels in normal glucose conditions with low nitrite levels in the absence of stimulation
and a significant increase when the cells were stimulated. In contrast, there was no
significant difference between the real-time NO measured and the nitrite levels that
accumulated in the media in high glucose conditions with and without stimulation (Figure
3). The nitrite level in the media is not a reliable proxy for the actual level of NO produced
by the cell. The iNOS enzyme that produces NO when cells are stimulated with
inflammatory mediators was expressed at a low level in all the treatment groups and the
proliferation of fibroblast cells from 24 to 72 hours showed no statistical difference
between normal and high glucose conditions in the absence or presence of LPS and INF-ƴ
(Figure 5 and 6 respectively). The results presented here clearly illustrate why nitrite
accumulation should not be used to predict NO production in cells and clearly indicates
that real-time NO measurement is essential in providing information that will allow a more
complete understanding of how NO may affect the proliferation, migration and formation
of extracellular matrix in fibroblast cells as well as the NO production in other cells present
at the wound site. If we accurately measure the actual levels of NO produced by cells
cultured under specific conditions, including the temporal NO release profile, we can
understand and mimic the physiological NO release at different stages of wound healing
and different pathological states, which will facilitate a smooth transition of the wound

34

from its chronic state into resolution, consequently, shortening the time to complete healing
of DFU.
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3 INVESTIGATIVE
STUDY
OF
REAL-TIME
NO
MEASUREMENTS IN WOUND FIBROBLAST CELLS IN
NORMAL AND HIGH GLUCOSE CONDITIONS3
Nitric oxide plays a key role in cardiovascular, immunology and respiratory
physiopathology. In patients affected with coronary artery disease who were undergoing
surgical procedures, the continuous administration of the NO drug nitroglycerin
significantly reduced the risk of myocardial infarction compared to control patients[190].
Another study reported a very impressive reduction in mortality for patients with advanced
heart failure treated with another NO drug isosorbide dinitrate[156]. For pediatric patients,
exhaled NO is a non-invasive diagnostic tool to identify the severity of asthmatic episodes
and control the administration of corticoid treatments[191]. However, its role in wound
healing is not as well defined. Several studies have shown the beneficial effect of NO
treatments in invitro models of migration ad cell proliferation as well as accelerated healing
in mouse models (Table 1-3). In addition, the previous chapter and other researchers have
demonstrated NO levels and iNOS protein expression or activity from normal human skin
fibroblasts[43, 192]. Unfortunately, the translation of the results obtained in vivo and
invitro have not been as straight forward in clinical application. Only one study so far has
shown a positive effect of NO treatment in patients affected with DFU but even in this
study, the major criticisms was that the absolute effect of NO on improved healing in these
patients compared to patients treated with the control could not be determined [149, 193].
Moreover, the NO levels at the wound site was also not known [193]. A number of studies
have reported the nitrite and nitrate levels in the wound fluid of acute and chronic wounds
which could be an indicator to estimate correlation of NO to the healing of wounds in the
patient[194-196]. However, it does not provide information on the timing/dose of NO
required or which cells are responsible for the NO production at the time the samples are
collected or when the measurements are taken. The majority of these studies also rely on
the Griess assay which has been proven to have a wide range of variability and low
sensitivity [151, 152]. Cells produce varying NO levels at different stages of the wound
healing process. The unpredictable and delicate environment of chronic wounds further
complicates this NO production in the cells. Without precisely comparing the levels of
nitrite/nitrate in the wound fluid to the actual levels of NO produced from the cells present
at the wound site, it is inaccurate if not impossible to determine the effect of NO on the
wound healing cascade even when the NO treatment is applied. In this chapter, the NO
levels produced from wound fibroblasts isolated from a patient with a chronic ulcer is
determined. In addition, using highly sensitive chemiluminescence detection the nitrite
levels in the cell culture media and at the wound site are also measured and compared to
the real-time NO levels detected from the cells.

3

Part of the work in this chapter will be submitted to a journal for future publication
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3.1 Materials and Methods4
3.1.1

Cell culture and chemical supplies

Primary human adult dermal fibroblasts (HDFa, ATCC® PCS-201-012™,), mouse
macrophages (RAW 264.7), penicillin streptomycin, fetal bovine serum (FBS), phosphate
buffered saline (PBS), and Dulbecco’s modified eagle medium (DMEM high glucose
4500mg/l) were all purchased from ATCC (Manassas, VA). Human aortic endothelial cells
were purchased from Gibco life technologies (Carlsbad, CA). DMEM (no glucose),
sodium pyruvate and Hoescht dye were obtained from Fischersci (Hanover Park, IL). D(+)-Glucose, Lipopolysaccharide pseudomonas aeroguinosa (LPS), Calcein-AM, protease
inhibitor cocktail, mouse nitric oxide synthase and dopamine-HCl were purchased from
Sigma-Aldrich (St. Louis, MO). Ethidium bromide was acquired from Invitrogen (Grand
Island, NY). Human recombinant Interferon gamma (hrIFN-Ƴ) was purchased from
GenScript (Piscataway, NJ). The primary and secondary antibodies against CD90/Thy1
(ab23894) protein and nitric oxide synthase (PAN 2977) were purchased from Abcam
(Cambridge, MA) and cell signaling technology (Danvers, MA) respectively. The 7.5%
SDS polyacrylamide gels and gelatin were acquired from Bio-Rad (Hercules, CA). The
Odyssey western blot starter kit 2 was obtained from LI-COR (Lincoln, NE). Silicone
elastomer base and curing agent (Dow Corning Sylgard®184) were obtained from ML
Solar LLC (Campbell, California). Sodium nitrite and nitrate, potassium iodide,
Aspergillus nitrate reductase, nicotinamide adenine dinucleotide phosphate hydrogen
(NADPH), flavine adenine dinucleotide (FAD) potassium mono and dibasic phosphate
(KHPO4) were all purchased from Millipore sigma (St. Louis, MO, USA). Glacial acetic
acid was obtained from BDH analytical chemicals VWR (Batavia, IL, USA).
3.1.2

Biopsy tissue and wound fluid collection

A biopsy sample and wound fluid were obtained from a patient in an ongoing clinical study
(IRB Number 1146644-4)) following procedures approved by the institutional review
board of Michigan Technological University. The sample was immediately processed for
cell isolation by a procedure adopted from Vangipuram et al [197].
3.1.3

Cell characterization

The wound cells at passage 3 were cultured in 12 well plates at a cell density of 1 ×104/cm2
in normal (5.5 mM) and high glucose (25 mM) conditions. At confluency, the cells were
fixed in 4% paraformaldehyde for 10 minutes, rinsed 3 times in phosphate buffered saline,
incubated in blocking buffer for 90 minutes followed by the primary antibody for 18 hours
at 4°C. The cells were rinsed 3 times in blocking buffer and incubated for 1 hour at room
The materials and methods were adopted from chapter 2 [42]. The rights to use the content is presented in
appendix C and licensed under Creative Commons Attribution 4.0 International License.
4
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temperature with the secondary antibody, stained with 4', 6-diamidino-2-phenylindole
(DAPI) and viewed under an Olympus fluorescent microscope (model BX51).

3.1.4 Real time NO measurements from wound fibroblasts
Primary wound dermal fibroblasts from passage 2-5 were cultured and expanded in
conventional cell culture plates (100mm) in DMEM (high or normal glucose levels), 10%
FBS and 1 % penicillin/streptomycin (complete growth media). At confluency, the cells
were reseeded in the CellNO trap devices at a density of 0.25-1 ×104 cells/cm2. The devices
were made using the procedure that was previously described[152]. After 24-72 hours, the
cell culture media was changed and substituted with media containing 40µg/ml of LPS and
200 U/ml of hrIFN-Ƴ or complete growth media (control) under normal glucose (5.5mM)
and high glucose (25mM) conditions. The device was placed in a standard incubator (37°C,
65% humidity, 5% CO2) and was connected to a calibrated nitric oxide analyzer (NOA)
and the real-time NO release profile was measured for 24 hours.
3.1.5

Cell viability assay in the CellNO trap device

After 24 hours, the live-dead assay was carried out using 2µM calcein AM, 2µg/ml
ethidium bromide and 10µg/ml Hoescht dye in DMEM media for 10-15 minutes. The cells
were imaged and analyzed using an Olympus fluorescent microscope (model BX51) and
Image J1 respectively[169].
3.1.6

Nitrite assay

After 24 hours of measurement in the CellNO trap device, the cell culture media from the
cell samples under normal and high glucose conditions were collected. The triiodide assay
was used to measure the nitrite accumulation in the media[74]. Briefly, 50µl of the media
was added to a vial containing a stirring solution of 300µl of glacial acetic acid and 120µl
of potassium iodide. The vial was connected to a calibrated Sievers Nitric Oxide Analyzer
280i (Zysense, LLC, Boulder, CO, USA) and the NO produced from the nitrite present in
the media was measured and normalized to the number of live cells.
3.1.7

Western blot analysis

Confluent wound fibroblast cells cultured in 100mm diameter tissue culture dishes were,
stimulated with 40µg/ml of LPS and 200U/ml IFN-Ƴ in normal and high glucose
conditions and incubated for 72 hours. Mouse macrophage cells RAW 264.7 grown to
confluency and stimulated with 1ug/ml of LPS for 18 hours and human aortic endothelial
cells served as positive controls for iNOS and eNOS respectively. The cells were quickly
washed in ice cold PBS, trypsinized, centrifuged and re-suspended in 200µl of RIPA buffer
in the presence of protease cocktail inhibitors. The cell lysates were incubated for 30
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minutes on ice on a plate shaker and centrifuged at 12,000 rpm for 20 minutes at 4°C. The
supernatant was collected, and the protein concentration determined for each sample using
Bradford assay[170]. An equal amount of loading buffer containing dithiothreitol was
added to each sample, boiled at 100°C for 5 mins and immediately placed on ice for 2 mins.
Approximately 10-14µg of protein was loaded in a 7.5% SDS-PAGE gel and separated by
electrophoresis at 100V for approximately 70 minutes. The proteins were transferred to
immobilon®-FL PVDF membrane using the Trans-Blot® Turbo™ Transfer System (BioRad) for 7 minutes. The membrane was incubated in Odyssey blocking buffer (TBS) for
60 minutes to block nonspecific binding sites followed by incubation in TBS containing
0.2% of tween20 (TBS-T) and the iNOS antibody (1:1000 dilution) for 18 hours at 4°C.
After that, the membrane was washed 4 times with TBS (0.1% tween20) and incubated in
TBS-T with the secondary antibody (1:20000 dilution) for 1 hour then extensively washed
in TBS, visualized by LI-COR Odyssey infrared imager and analyzed using Image Studio
Lite Software Version 5.2.

3.1.8

Nitrite and nitrate measurements from wound fluid

Swabs containing wound fluid were sterilized under ultraviolet light for 1 hour prior to
experiments performed. The swabs were soaked in 500 µl of deionized water and sonicated
for 10 minutes. These samples were prepared for nitrite and nitrate measurements using a
procedure adopted from Gilliam et al with minor modifications[198]. Briefly for each
nitrite standard solution, final reaction volume containing 40 µl of 0.14M of potassium
phosphate buffer pH 7.5, 35 µl of deionized water and 25 µl nitrite standard was prepared.
For the nitrate standards, a final reaction volume containing 40µl of 0.14M KHPO4 buffer
(pH 7.5), 26.8µl of deionized water, and 2.5 µl OF 100 µM FAD, 4µl OF 2.5mM NADPH,
25 µl of standard and 1.7 µl of 3.5U/ml of nitrate reductase was prepared. The samples
were left to incubate for 24 hours at room temperature to convert all nitrate into nitrite.
3.1.9 Nitrite and nitrate standards preparation
Stock solutions of nitrite and nitrate standards were prepared to a final concentration of 10
mM in deionized water. The stock solutions were diluted in deionized water to make
standard solutions ranging from 0- 50 µM and 0-150µM. The solutions were prepared as
previously described.
3.1.10 Blinded concentrations of nitrite and nitrate
Three standard samples containing different ratios of nitrite and nitrate concentrations were
prepared using the same procedure for the nitrite and nitrate calibration standards. Another
researcher was blinded to the concentrations of these standards during measurements.
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3.1.11 Chemiluminescence detection method for nitrite measurements
50 µl of each of the standards and samples, was injected into a vial containing a bubbling
solution of 300 µl of glacial acetic acid and 120 µl potassium iodide in order to reduce all
the nitrite into nitric oxide (NO). The vial was connected to a calibrated Sievers nitric oxide
analyzer 280i (NOA) (Zysense, LLC, Boulder, CO, USA) to measure the total NO released.
The background signal from the NOA before injecting the standards and samples was
averaged for 1 minute and subtracted from each data point measured prior to integrating
the area under the curve. Two calibration curves were determined for nitrite and nitrate
standards. The nitrite calibration curve was used to calculate the concentration in the
blinded standards and clinical samples. The concentration of nitrate was determined as the
difference in the nitrite and the total nitrite measured from the nitrate samples. The
experiments were performed as 3-5 replicates and the data obtained was analyzed in
Microsoft Excel.

3.2 Results
3.2.1 Characterization of cells isolated from biopsy sample cultured in
normal and high glucose conditions
The migration of the cells from the biopsy tissue took approximately 3 weeks. The cells
appeared to grow well and different cell populations could be observed within the cell
culture (Figure 2-1).

Figure 3-1. The cell isolation from a human skin biopsy sample. Arrows represent
different cell populations observed
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Cells at passage 3 cultured in 12 well plates in normal and high glucose conditions for 24
hours were elongated and spindle shaped which is commonly associated with confluent
fibroblast cells (Figure 3-2A and 3-2B). In addition, the cells showed uniform staining of
CD90, a characteristic marker frequently used to identify fibroblasts in primary cultures
(Figure 3-2 C and 3-4 D).

Figure 3-2. The characterization of cells isolated from the biopsy tissue. Phase contrast
images showing morphological appearance of isolated cells cultured in (A) normal
(5.5mM) and (B) high glucose (25mM) conditions. Immunofluorescent staining of Green
(CD90) and Blue (cell nuclei) for the cells cultured in (C) normal and (D) high glucose
conditions. Scale bar 400µM

3.2.2

Real- time NO measurements of wound fibroblasts cultured in
normal and high glucose conditions

The real-time NO release in wound fibroblasts cultured in normal and high glucose
conditions was measured for 24 hours with and without stimulation (Figure 3-3).
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Figure 3-3. The real-time NO profile detected in wound fibroblasts cultured in
normal (5.5mM) and high (25mM) glucose conditions with (+) and without (-)
stimulation.
Cells cultured in normal glucose media without stimulation did not show any detectable
NO measurements. When the cells were stimulated with inflammatory mediators, there
was an increase in NO detected after 1 hour that peaked at 24 hours (1.03×10-11 (moles/
(min.cm2))/105cells). The cells cultured in high glucose without stimulation showed very
low NO levels which also peaked at 24 hours (2.59×10-12(moles/(min.cm2))/105cells).
When stimulated there was no detectable NO measured up to 20 hours. At this time point,
there was an increase in NO detected which peaked at 24 hours but still lower than normal
glucose with stimulation (5.27×10-12(moles/(min.cm2))/105cells). The wound fibroblasts
maintained over 95% cell viability in all the treatment groups (Figure 3-4)
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Figure 3-4. Cell viability detected by calcein AM and ethidium bromide for wound
fibroblasts cultured in normal (5.5mM) glucose condition without and with
stimulation, A and B respectively and high glucose (25mM) without and with
stimulation C and D respectively. Scale bar 500µm.
3.2.3

Nitric oxide detected from nitrite accumulation in the absence and
presence of stimulation

At the end of the real-time NO measurements, the media in the cell cultures was collected
and assessed for nitrite accumulation using the triiodide assay [74]. The NO detected from
the total nitrite accumulated in the media was compared to the integrated area under the
curve for the real time NO detected from the cells (Figure 3-5). The cells cultured in
normal glucose without stimulation showed absence of real time NO levels which was
increased when stimulated (4.08±3.38nmol/105 cells). There was nitrite detected in normal
glucose without stimulation, although lower compared to stimulated cell cultures
(0.77±1.34 vs 1.52±2.64 nmol/105 cells). In high glucose conditions, both total NO and
nitrite in the media could be detected in the absence of stimulation (0.61±1.06 vs 0.77±0.48
nmol/105 cells). However, with stimulation in high glucose conditions, there was no
detectable accumulation of NO or nitrite after 24 hours. Overall there was no significant
differences among all the treatment groups for 3 independent experiments.
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Figure 3-5. The total NO compared to nitrite accumulation in the cultured
media determined for wound fibroblasts cultured under normal (NG) and high
(HG) glucose conditions in the absence (-) and presence (+) of stimulation
(n=3).
3.2.4

Western blot
quantification

analysis

for

iNOS,

eNOS

and

NF-κβ

protein

Wound fibroblasts at passages 2-4 were cultured in 100mm diameter dishes and at
confluency were stimulated with 200U of IFN-Ƴ and 40 µg/ml of LPS for 72 hours.
Western blot analysis showed absence of inducible NOS in all treatment groups (Figure
3-6). An independent experiment was run to determine the presence of constitutively
expressed NOS isoforms (eNOS and nNOS) using a universal NOS antibody that can detect
all three isoforms. RAW 264.7, human aortic endothelial cells were used as a positive
control for iNOS and eNOS respectively. The results showed faint bands at the predicted
molecular weight of eNOS and these bands were the same band size as the positive control
(HAEC). Endothelial nitric oxide synthase levels were low in unstimulated wound
fibroblasts cultured in normal and high glucose without stimulation compared to stimulated
cells and in both cases the levels were higher in high glucose compared to normal glucose
conditions (Figure A1). In addition, the protein levels of the transcription factor NF-κβ that
is upstream in the pathway that leads to iNOS expression was determined and was found
to be increased in stimulated wound fibroblasts cultured in normal and high glucose
conditions compared to unstimulated cells. The levels were higher in high glucose with
stimulation compared to normal glucose conditions (Figure A2).
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Figure 3-6 Western blot analysis to determine iNOS protein in wound
fibroblasts cultured in normal glucose (NG) and high glucose (HG) in the
absence (-) and presence (+) of stimulation (n=3). GAPDH was used as
the housekeeping protein.
3.2.5 Nitrite and nitrate measurements from wound fluid
Nitrite and nitrate standard solutions were prepared with concentrations of 0-50 µM. The
nitrate was converted to nitrite by the enzyme nitrate reductase and the NO released from
the nitrite solutions was measured and used to obtain two calibration standard curves.
Figure 3-7 shows the linearity of the curves obtained. The results clearly indicate that the
enzyme converted almost all the nitrate into nitrite. Chemiluminescence detection showed
a minimum sensitivity level of 0.05-0.1µM of nitrite (Figure A3). The enzyme converted
nitrate concentrations of up to 150µM which was observed from the linearity and
superposition of nitrite and nitrate curves of the same concentration. (Figure A4).
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Figure 3-7. Calibration curves obtained from nitrite and nitrate standards for
concentrations ranging from 0-50µM.
Three samples containing a combination of standard nitrite and nitrate concentrations were
prepared and processed. The nitrate in the samples was converted into nitrite by the enzyme
nitrate reductase and the nitrate was calculated by subtracting the total nitrite from the
nitrite only preparations. The researcher was blinded to the concentrations in the samples
during measurements. This was performed in order to determine the accuracy of our
method to assess unknown levels of nitrite/nitrate present in clinical wound swab samples.
Three ratios were prepared; 2:1 (T19), 1:1 (T20) and 1:2 (T21) of nitrite to nitrate
concentrations. The analysis showed (Figure 3-8) that two of the samples (T20 and T21
maintained the theoretical ratio that was prepared before processing and taking
measurements while T 21 showed a slight deviation of the ratio prepared (2.3:1 versus 2:1).
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Figure 3-8. Samples containing combination of known standard nitrite and nitrate
concentration. 2:1 (T19), 1:1 (T20) and 1:2 (T21) of nitrite to nitrate concentrations. For
n=3

The data proves that it is reliable to use this method to determine nitrite and nitrate levels
present in wound fluid. The swab with fluid that was obtained from the wound site from
which the cells were isolated was analyzed for nitrite and nitrate using the method
described above. The results (Figure 3-9) showed a higher nitrite concentration in the
wound fluid compared to nitrate for 5 independent replicate measurements (60.25±1.79
µM vs 27.42±3.91 µM). Moreover, the NO detected was 1000-fold higher than the total
direct NO measured in wound fibroblasts in both normal and high glucose conditions.
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Figure 3-9. Total NO released from the nitrite and nitrate concentration measured
from wound swab sample. For n=5 at p< 0.05 * represents statistical significance
between the groups.

3.3 Discussion
The goal of this study, was to establish a protocol that can be used to assess the levels of
NO produced by cells in the wounds of patients affected with DFU and compare the NO
levels to the nitrite/nitrate present in the wound bed in order to clearly delineate the
bioavailability of NO in the chronic wound. We were able to successfully isolate, expand
and culture wound fibroblasts from a biopsy sample obtained from a patient with an ulcer.
Establishing primary cultures from chronic wounds is challenging and, in some cases, the
cells have a lower proliferative capacity and altered morphology compared to normal
fibroblasts[199-202]. Overall, although the cell yield was lower than normal fibroblasts,
the cells obtained in this study exhibited morphology and markers characteristic to
fibroblasts and the cells maintained relatively uniform growth function through passage 5.
Furthermore, the wound fibroblasts achieved greater than 95% viability in the NO
measurement device (Figure 3-4). The real-time NO levels could be detected in the cells
using this system. The cells cultured in normal glucose media without stimulation showed
absence of NO detected which was similar to normal skin fibroblasts. When stimulated
with inflammatory mediators, there was an increase in NO detected however the NO profile
was markedly different (Figure 3-3) and lower compared to normal fibroblasts cultured
under the same conditions (Figure 2-1). The sample used in this chapter is part of an
ongoing blinded clinical study (IRB 1146644-1) and therefore, it is interesting to note that
the cells obtained were isolated from the biopsy of a non-diabetic patient with a chronic
wound aged one year and 8 months. Studies have suggested that there is a deficiency or
reduced availability of NO in chronic wounds both diabetic and non-diabetic[85, 161, 203].
In addition, chronic wounds have a common finding which is the persistent production of
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reactive oxygen /nitrite species as well as a reduced antidefense mechanism[203]. This is
the first study to report the levels of real-time NO produced from cells isolated from a
human chronic wound and our preliminary data has shown a possible reduction of NO
produced from wound fibroblasts obtained from chronic wound tissue. We also measured
the change in the NO detected when the cells were cultured in high glucose conditions with
and without stimulation and the results also showed suppressed NO levels compared to
normal skin fibroblasts. The NO levels measured after 24 hours was compared to the nitrite
present in the cell culture media. In normal glucose conditions, the trend remained
consistent with normal skin fibroblasts with the data showing increased NO and nitrite
levels for stimulated cells compared to unstimulated cells (Figure 3-4). A key finding was
detectable nitrite (0.77±1.34 nmols/105 cells) in normal glucose without stimulation and
absence of real-time NO under the same treatment conditions. During the normal wound
healing process, cells such as the immune cells, endothelial cells, fibroblasts and
keratinocytes produce proportional amounts of ROS (superoxide)[203]. Superoxide reacts
very rapidly with NO to produce the more toxic compound peroxynitrite that can be
oxidized into nitrite/nitrate as well[129]. Fortunately, antioxidant mechanisms are present
to modulate the production and levels of superoxide in order to increase the bioavailability
of NO to the cells. For example, the enzyme superoxide dismutase present at the wound
will convert superoxide into hydrogen peroxide and the enzyme catalase will then convert
the hydrogen peroxide into oxygen and water[203]. Our finding suggests that there might
be high levels of ROS that surpass the antioxidant mechanisms in chronic wound cells that
leads to absence of NO detection and the presence of nitrite. High glucose conditions
without stimulation showed low levels of nitrite similar to the real time NO measurements
under the same conditions. However, there was neither nitrite nor total NO detected for the
cells cultured in high glucose with stimulation (Figure 3-5). Western blot analysis was
performed for the wound fibroblasts to assess the upregulation the NOS enzymes known
to be responsible for NO production. The data showed absence of the inducible nitric oxide
synthase enzyme (Figure 3-6). Although, the NF-κβ protein which is the principal
transcription factor that activates the genes responsible for the production of iNOS was
upregulated with increased levels in stimulated cells (Figure A-2). Whether this could be
an indication of an interference in the pathway that leads to upregulation of the iNOS
enzyme still needs to be determined. We also assesed protein levels of constitutively
expressed NOS isoforms using a universal NOS antibody and faint bands were observed
that corresponded to the molecular weight of eNOS. The results showed a trend for higher
protein levels in stimulated compared to non-stimulated wound fibroblasts (Figure A-1).
Endothelial nitric oxide synthase and its activity has been identified in cultured human skin
fibroblast cells[43, 204]. It has also been proposed as a mechanism to increase ROS in
diabetic and chronic wounds through its uncoupling from the NO pathway to produce
superoxide instead[203]. Only one replicate measurement was run to determine the
presence of constitutively expressed NOS isoform enzymes and we cannot draw a
definitive conclusion with the results so far. However, it shows that further studies will
need to performed to determine the role of eNOS in the dysregulation of chronic wounds.
There was no statistical difference obtained within the groups for the real time/nitrite
measurements and a large variation in NO and nitrite detected for 3 independent
experiments was observed. This could be attributed to the altered state of the cells that
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resided in a persistent chronic state for over a year. Caley et al[201] reported a reduced
reproducibility in cells isolated from chronic wounds and the reason is that the cells take
on a distinct phenotype in the chronic wound bed that is ultimately retained even in invitro
cell culture. To support this hypothesis Schaffer et al [44] assessed NO/nitrite production
in cells isolated from a wounded rat model. The cells isolated from the wound only
produced NO in the first two passages. This phenomenon might also be observed in
primary cells obtained from a chronic wound.
Experiments were performed to determine the nitrite/nitrate levels present in the wound
bed. The studies in the literature analyze the NO levels by looking at the nitrite/nitrate
present in the plasma/urine of the patient as well as the metabolites of the substrate arginine
that is present in the wound fluid[205, 206] while others use the fluid obtained in animal
wound models to predict the NO state and function .The data gives an overview of the NO
levels in the pathological states and how it could possibly affect the healing wound but it
does not give an accurate assessment of the NO levels or even nitrite/nitrate that is actually
present in a clinically relevant wound model. Besides, the Griess assay was mainly used to
determine these nitrite levels and it has been shown to have a low sensitivity (0.5µM)
[207] and the presence of blood components such as hemoglobin could greatly interfere
with the results obtained[208]. We established an effective method to analyze the
nitrite/nitrate present in the fluid of chronic wounds. The protocol used was adopted from
Gilliam et al[198] with some modifications. Nitrite and nitrate standard solutions with
equal concentrations were prepared and the nitrate was converted to nitrite by the enzyme
nitrate reductase. The nitrite was reduced to NO using the triiodide assay and the NO
released was measured using the most highly sensitive method for NO detection
(chemiluminescence). The results showed complete conversion of nitrate into nitrite
(Figure 3-6). To determine the accuracy of the method, 3 blinded samples containing
standard concentrations of both nitrite and nitrate were prepared and measured. The results
showed that the theoretical ratio matched up the experimental ratio obtained with slight
deviation in one of the samples (Figure 3-7) The detection limit was as low as 0.05-0.1µM
and for the enzyme concentration used, a linear response was maintained up to 150µM
(Figure A 3) validating that we can use this method to analyze low and high nitrite
concentrations in wound fluid samples. We determined the nitrite/nitrate levels in the
wound fluid obtained from a human chronic wound (Figure 3-8). The nitrite in the wound
bed was found to be in the micromolar range which is one thousand-fold higher than the
NO that was detected in the cells (Figure 3-5). This confirms that tracking nitrite/nitrate
accumulation cannot be used to determine actual NO production during wound healing.
The rate of nitrite/nitrate clearance from the wound fluid is unknown. As NO decomposes,
nitrite and nitrate will accumulate in fluid, the wound bed will influence how quickly fluid
and ions are removed and this removal rate will likely change during the course of wound
healing. Additionally, the wound fluid is collected after the biopsy was obtained. This
might have provoked the hemostatic phase of wound healing, consequently increasing NO
production at the wound site. The data further proves that there are many factors that can
result in increased nitrite levels when the sample is collected at a specific time point and it
is precisely why it’s not accurate to rely only on these NO metabolites to predict the NO
role in a given pathology. The high nitrite concentration measured could also support a
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possible reduction of NO bioavailability to cells in and surrounding the wound bed from
high ROS levels and low antioxidants. There is also the possibility of other cells such as
the immune cells that persist in the chronic wound that are responsible for the high nitrite
levels measured. The levels of nitrite were significantly higher compared to the nitrate level
(60.25±1.79 µM vs 27.42±3.91 µM). Hemoglobin is an effective scavenger of NO. It
reduces NO concentration by oxidizing NO predominantly into nitrate. Therefore, in the
event of an increased hemostatic response, it is expected that NO produced would oxidize
primarily to nitrate but this was not the case. The toxic NO metabolite peroxynitrite
oxidizes significantly to nitrite at a pH of 7.5[129]. At lower pH levels (pH 3) it is
predominantly oxidized to nitrate. Chronic wounds have been reported to have pH values
ranging from 7.19-8.5 that is also taken as an indicator of the delayed healing status of the
wound[209]. The pH at the wound used in this chapter was not determined in our study
and it’s also not know whether higher pH values (>7.5) or other components in the wound
environment will result in more decomposition of peroxynitrite into nitrite. However, our
data shows that further study on the metabolic fate of peroxynitrite is warranted.

3.4 Conclusion
In this chapter, the real-time NO and nitrite levels detected in wound fibroblasts isolated
from a chronic wound cultured in normal and high glucose conditions for a duration of 24
hours was assessed. The results show that the NO production is altered in fibroblasts
isolated from a chronic wound tissue. In addition, we validated a method to determine the
nitrite/nitrate levels present in wound fluid. The nitrite/nitrate levels in wound fluid was
1000-fold higher than the NO levels measured in the cells which suggests that there is a
dysregulation in NO levels in chronic wounds that could explain the delayed healing in the
patient. The work presented proves that we can determine the real-time NO levels from
cells isolated from patients with chronic wounds as well as the nitrite/nitrate present at the
wound site. Combining the data obtained from these two methods of analysis coupled with
measuring protein levels of the different enzymes/factors that might affect the
bioavailability of NO will indeed offer better insight on the exact timing, dose and duration
of NO treatment that is required to restore the milieu interieur in the chronic wound and
lead to complete healing for patients.
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4 INVESTIGATIVE
STUDY
OF
REAL-TIME
NO
MEASUREMENTS IN MOUSE MACROPHAGE CELLS
(RAW 264.7) IN NORMAL AND HIGH GLUCOSE
CONDITIONS5
Macrophages are one of the most important cell types during wound healing. They are the
guardians of the innate immune system and are involved in initiating and resolving the
inflammatory response. Macrophages also facilitate the transition of the wound from the
inflammatory to the proliferative phase and have the capacity to influence all other phases
of the wound healing process. This was demonstrated in macrophage deficient wound mice
models. The wounds resulted in reduced collagen synthesis and granulation formation,
insufficient secretion of growth factors, low levels of myofibroblast cells and ultimately
delayed wound closure[210]. The multifunctional roles of macrophages are possible
because they can take on different functional phenotypes during the progression of wound
healing. The most commonly known phenotypes are the classical (M1) and alternative
(M2) macrophages. The former being pro-inflammatory and the latter antiinflammatory[211]. On activation by inflammatory cytokines and/or bacterial products,
M1 secrete large amounts of reactive oxygen and nitrogen species as well as other
inflammatory mediators which act to disinfect the wound and recruit cells to the wound
site[31, 32]. The M1 are also phagocytic cells and act by clearing the wound bed of cell
debris. When the wound bed is appropriately prepared, the M1 phenotype changes to an
M2 phenotype that does not produce ROS /RNS. Instead, these cells resolve the
inflammatory process and are mainly involved in promoting cell proliferation and tissue
repair by producing growth factors VEGF, TGF-β and Insulin like growth factor-1[210]
This change is critical for the transition of the wound from the inflammatory to the
proliferative stage of wound healing. The alteration in the phenotypes of macrophages has
been greatly linked to the development of DFU and it is reported that factors and
mechanisms that regulate glucose and lipid metabolism facilitate the change from M1 to
M2 [122] Moreover, paracrine factors produced from both M1 and M2 macrophages have
been shown to influence the phenotype and function of fibroblast cells [212]. Human skin
fibroblasts cultured in M1 conditioned media expressed more pro inflammatory genes and
produced more ECM degrading enzymes compared to the fibroblasts cultured in
conditioned M2 media which exhibited increased ECM production and proliferation
potential. Chronic wounds are often stalled in the inflammatory phase of wound healing
and the altered phenotype and function of macrophages could explain the persistence of
DFU in this phase [213]. Nitric oxide is the principal compound produced from M1
macrophages. Previous studies from our lab have clearly elucidated the real- time NO
profile from the macrophage cell line RAW 264.7[152]. The nitrite accumulation and
protein levels in these macrophages has also been well characterized from these cells.
Additionally, RAW 264.7 cells have been widely used in the literature as a positive control
to validate NO production in cells[132, 214, 215]. However, the real-time NO profile of
5

The work in this chapter will be submitted to a journal for future publication.
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RAW 264.7 cells cultured in normal and high glucose conditions and how it compares with
the nitrite has not been previously explored. In addition, RAW 264.7 is also phenotypically
and functionally stable through 30 passages [215]. Therefore, it allows us to validate the
results from the two previous chapters that have shown that high glucose suppresses NO
produced from the cells. A detailed understanding of the dynamic changes of NO produced
from macrophages cultured in normal and high glucose conditions might be the key that
unlocks the door to accelerated healing in chronic wounds such as DFU.

4.1 Materials and Methods6
4.1.1 Cell culture and chemical supplies
Mouse macrophage cell line RAW 264.7 (ATCC TIB-71), penicillin streptomycin, fetal
bovine serum (FBS), phosphate buffered saline (PBS), and Dulbecco’s modified eagle
medium (DMEM high glucose 4500mg/l) were all purchased from ATCC (Manassas, VA).
DMEM (no glucose), sodium pyruvate and Hoescht dye were obtained from Fischersci
(Hanover Park, IL). Lipopolysaccharide pseudomonas aeroguinosa (LPS), Calcein-AM,
protease inhibitor cocktail and dopamine-HCl were purchased from Sigma-Aldrich (St.
Louis, MO). Ethidium bromide was acquired from Invitrogen (Grand Island, NY). The
7.5% SDS polyacrylamide gels, GAPDH antibody (VPA00187) and gelatin were acquired
from Bio-Rad (Hercules, CA). Nitric oxide synthase antibody (PAN) (2977) was purchased
from cell signaling technology (Danvers, MA). The secondary antibodies; IR dye®680RD
and 800CW goat anti-mouse and anti-rabbit, Odyssey blocking buffer, immobilon-FL
transfer membrane and the chameleon duo pre-stained protein ladder were obtained from
LI-COR (Lincoln, NE). Silicone elastomer base and curing agent (Dow Corning
Sylgard®184) were obtained from ML Solar LLC (Campbell, California).

4.1.2 Real time NO measurements from macrophages cells RAW 264.7
RAW 264.7 at passage 15 were cultured and expanded in conventional cell culture plates
(100mm) in DMEM (high or normal glucose levels), 10% FBS and 1 %
penicillin/streptomycin (complete growth media). At confluency, the cells were reseeded
in the CellNO trap devices at a density of 0.25-1 ×105 cells/cm2. The detailed fabrication
and characterization of the device has been previously reported [152]. After 24-72hours,
the cell culture media was changed and substituted with media containing 1µg/ml of LPS
or complete growth media (control) with normal glucose (5.5mM) and high glucose
The materials and methods were adopted from chapter 2 [42]. The rights to use the content is presented in
appendix C and licensed under Creative Commons Attribution 4.0 International License
6
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(25mM) concentrations. The device was placed in a standard incubator (37°C, 65%
humidity, 5% CO2) and was connected to a calibrated nitric oxide analyzer (NOA) and the
real-time NO release profile was measured for 24 hours.

4.1.3

Cell viability assay in the CellNO trap device

After the real-time NO measurements, a live-dead assay was carried out using 2µM calcein
AM, 2µg/ml ethidium bromide in PBS for 10-15 minutes. The cells were imaged and
analyzed using an Olympus fluorescent microscope (model BX51) and Image J1
respectively[169].

4.1.4

Nitrite assay

After 24 hours of measurement in the CellNO trap device, the cell culture media from the
cell samples under normal and high glucose conditions were collected. The triiodide assay
was used to measure the nitrite accumulation in the media[74]. Briefly, 50µl of the media
was added to a vial containing a stirring solution of 300µl of glacial acetic acid and 120µl
of potassium iodide. The vial was connected to a calibrated Sievers Nitric Oxide Analyzer
280i (Zysense, LLC, Boulder, CO, USA) and the NO produced from the nitrite present in
the media was measured and normalized to the number of live cells.

4.1.5 Western blot analysis
Confluent RAW 264.7 cells cultured in 100mm diameter tissue culture dishes were
stimulated with 1µg/ml of LPS in normal and high glucose conditions and incubated for
24 hours. The cells were scraped, centrifuged and re-suspended in 200µl of RIPA buffer in
the presence of protease cocktail inhibitors. The cell lysates were incubated for 30 minutes
on ice on a plate shaker and centrifuged at 12,000 rpm for 20 minutes at 4°C. The
supernatant was collected, and the protein concentration determined for each sample using
Bradford assay[170]. An equal amount of loading buffer containing dithiothreitol was
added to each sample, boiled at 100°C for 5 mins and immediately placed on ice for 2 mins.
About 30 µg of protein was loaded in a 7.5% SDS-PAGE gel and separated by
electrophoresis at 100V for approximately 70 minutes. The proteins were transferred to
immobilon®-FL PVDF membrane using the Trans-Blot® Turbo™ Transfer System (BioRad) for 7 minutes. The membrane was incubated in Odyssey blocking buffer (TBS) for
60 minutes to block nonspecific binding sites followed by incubation in TBS containing
0.2% of tween20 (TBS-T), GAPDH and the iNOS antibodies (1:1000 and 1:10000 dilution
respectively) for 18 hours at 4°C. After that, the membrane was washed 4 times with TBS
54

(0.1% tween20) and incubated in TBS-T with the secondary antibody (1:20000 dilution)
for 1 hour then extensively washed in TBS, visualized by LI-COR Odyssey infrared imager
and analyzed using Image Studio Lite Software Version 5.2.
Statistical analysis was performed in Microsoft Excel using a student’s t-test with statistical
significance set at a 95% confidence level (P<0.05).

4.2 Results
4.2.1 Real-time NO measurements from the macrophage cell line RAW264.7
Raw 264.7 cells cultured in the CellNO trap device in normal and high glucose media
showed absence of NO in unstimulated cells (Figure 4-1). After stimulation by the bacterial
product LPS (1µg/ml), there was a steady increase in NO detected after 3 hours in normal
glucose conditions which peaked at 12.5 hours (9.737×10-12(moles/(min.cm2))/106cells)
with a gradual reduction in NO detected at 24 hours (3.645×10-12 (moles/(min
.
cm2))/106cells). In high glucose conditions, NO was detected after 4 hours and it peaked
at 14.5 hours (2.212×10-12 (moles/(min.cm2))/106cells) and gradually decreased to (1.734
×10-12 (moles/(min.cm2))/106cells) at the end of 24 hours. The NO detected in normal
glucose condition was significantly higher compared to high glucose conditions as
observed in (Figure 4-1)

Figure 4-1. The average real- time NO surface flux from RAW 264.7
cultured in normal (5.5mM) and high glucose (25mM) media without (-)
and with (+) stimulation by LPS (1µg/ml)
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4.2.2

Nitric oxide detected from nitrite accumulation in the absence and
presence of stimulation

The nitrite accumulated in the media at the end of the real-time NO measurements was
analyzed using the triiodide assay[74]. In unstimulated cells, the levels of nitrite was very
low compared to stimulated cells in normal and high glucose conditions (2.32±0.32 vs
1.22±1.19 nmol/106 cells for n=3). When stimulated, the nitrite detected in normal glucose
conditions was slightly higher than the nitrite detected in high glucose but not statistically
different (58±14.30 vs 36±10.72 nmol/106cells for n=3) (Figure 4-2).

Figure 4-2 The comparison between the accumulated real-time NO and the nitrite
measurements for normal (NG) and high (HG) glucose the absence (-) and presence
(+) of stimulation. For n=3, * represents statistical difference in real time NO in
NG+ and HG +. # represents statistical difference in real-time and nitrite in NG+
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4.2.3 The cell viability for RAW 264.7 cells cultured in normal and high
glucose conditions in the absence and presence of stimulation
At the end of the real-time NO measurements, the cell viability was assessed using a live
dead assay as previously described. Overall the cells maintained good viability in all
treatment groups. Normal glucose conditions with stimulation had a lower cell viability
compared to normal glucose without stimulation and high glucose without and with
stimulation. (Figure 4-3). However, the difference was not statistically different.

Figure 4-3 The cell viability detected by calcein AM and ethidium
bromide for RAW 264.7 cultured in normal (NG) and high (HG)
glucose media in the absence (-) and presence (+) of stimulation

4.2.4

The total real time-NO released compared to the nitrite accumulated
in the media

The real-time NO detected was integrated to obtain the total NO released and it was
compared to the nitrite detected in the cell culture media (Figure 4-2). The total NO
released in normal glucose conditions with stimulation was significantly higher compared
to the nitrite that was collected in the culture media (161.80±29.05 vs 58±14.30 nmol/106
cells n=3, p=0.005). High glucose followed a similar trend, the total real-time NO measured
was higher compared to the nitrite although not statistically different (46.26±12.90 vs
36.05±10.72 nmol/106 cells). Interestingly, for the cells cultured in normal glucose
conditions, the total real-time NO analyzed was significantly higher than total real-time
NO measured in high glucose conditions when stimulated (161.80±29.05 vs 46.26±12.90
nmol/106cells n=3, p=0.00325). The nitrite measured was not statistically different in
normal and high glucose conditions with stimulation.
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4.2.5 Western blot analysis for iNOS protein levels in macrophages RAW
264.7 cultured in normal and high glucose conditions
RAW 264.7 cells seeded at the same cell density, were cultured in normal and high glucose
conditions. At confluency, the cells were stimulated with 1ug/ml of LPS for 24 hours. The
iNOS protein levels in the cells were analyzed using western blot. The results showed that
the iNOS protein was not detected in the cells cultured in normal and high glucose in the
absence of stimulation while the iNOS protein was upregulated in both normal and high
glucose when the cells were stimulated (Figure 4-4) with the highest levels in macrophages
cultured in normal glucose compared to high glucose conditions (23151.96 vs 7975.66,
n=3 p=0.02)

Figure 4-3. Western blot analysis for the detection of iNOS protein in
normal (NG) and high glucose (HG) in the absence (-) and presence (+) of
stimulation

4.3 Discussion
Diabetic foot ulcers remain stalled in the inflammatory stage of wound healing and it’s
suggested that the macrophages present in the wound retain their proinflammatory
characteristics making it impossible for the wound to proceed to resolution. Nitric oxide is
one of the key mediators produced by macrophages when faced with a hostile environment.
Our lab has previously reported real-time NO levels from macrophage cells (RAW 264.7)
cultured in high glucose conditions with stimulation by the inflammatory mediators LPS
and IFN-ϒ[152]. Herein, we determined the real-time NO levels produced in RAW 264.7
cultured in normal and high glucose conditions with and without stimulation by the
bacterial product LPS (1 µg/ml). In the absence of stimulation, NO was barely detectable
in the cells cultured in normal and high glucose media (Figure B-1). When the cells were
stimulated by LPS, the real-time NO in normal glucose conditions was significantly higher
compared to high glucose conditions (162± vs 46.25±1.29 nmols/106 cells). The results
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presented in this chapter showed consistency with previous work under high glucose
conditions[152]. Although slightly higher NO was detected in our study, it was still in the
same order of magnitude (46.25±1.29 vs 35.37±2.90 nmol/106cells). Our work reports the
first ever assessment of real-time NO produced from macrophage cells cultured in normal
glucose conditions. There has been a lot of controversy in the literature in regards to the
levels of NO in diabetic conditions (Table 2) and a similar trend is observed for
macrophages cultured in normal and high glucose conditions. Tseng et al [216] showed
that high glucose inhibited nitrite production and iNOS expression from macrophages
while other studies show that the nitrite and iNOS protein levels are elevated in RAW
264.7 cultured in high glucose states[132, 217-220]. The evidence presented in these
studies supports the results obtained by the authors. However, to base these findings purely
on the metabolites of NO is not an accurate assessment. Nitric oxide reacts with a large
number of oxidative molecules such as oxygen, transition metal ions, thiols to form other
compounds, some of which metabolize to produce the same biproducts (nitrate and nitrite)
as NO [203]. Moreover, depending on the surrounding environment, the NOS enzymes can
also uncouple from its native NO metabolic pathway to generate the reactive oxygen
species superoxide[96]. It is therefore critical to compare the actual levels of NO that the
cells experience to the molecular pathways, protein levels and even culture environment
that might affect the NO release or availability. The iNOS levels in our study strongly
correlated with the real-time levels of NO observed in both treatment groups in the
presence and absence of stimulation (Figure 4-2 and 4-4) with higher levels in normal
glucose compared to high glucose conditions with stimulation (23151.96 vs 7975.66, n=3
p=0.02). Miao et al[35] showed reduced iNOS expression and levels in macrophages
isolated from the wounds from diabetic mouse. The same group also observed increased
arginase expression in the macrophages present in the wound suggesting a greater
population of alternatively activated or altered macrophage function in the diabetic wound.
Other researchers have reported iNOS deficiency from genetically diabetic mice.
Furthermore, the administration of NOS inhibitors has also been shown to delay
reepithelialization and collagen formation[221]. The nitrite that was accumulated in the
culture media was compared in both treatment groups and it was found to be slightly higher
in normal glucose compared to high glucose with stimulation but not statistically different.
The total real-time NO was significantly higher in normal glucose compared to the nitrite
inferred in the cell culture media of the same treatment group while the nitrite and total NO
in high glucose conditions was not significantly different (Figure 4-2). Macrophages
produce both nitric oxide and superoxide when activated as part of the cell immune
response[32]. Nitric oxide has a very strong affinity for superoxide and the reaction
between the two species produces the more toxic compound peroxynitrite[58, 115].
Depending on the pH, peroxynitrite is oxidized to nitrite or nitrate[129]. In the presence of
antioxidant molecules, the formation of this compound is modulated by scavengers of
superoxide and nitric oxide [96]. High glucose levels alter the redox environment of the
cells through various mechanisms[222]. One is through superoxide generation from the
mitochondria which can activate the polyol pathway, increase consumption of NADPH a
key cofactor required for NO synthesis and the activity of antioxidant molecules. The low
NO levels in high glucose compared to normal glucose cell culture conditions that could
be explained by this mechanism. The results strongly suggest a possible increase in
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nitrosative stress for cells cultured under high glucose conditions. He and Frost[153] have
shown that the generation of the reactive oxygen species such as superoxide greatly reduces
the real-time NO levels produced from known NO donors and a similar mechanism might
be observed in the cells. In addition, chronic wounds of patients have been found to have
high levels of uncontrolled ROS and RNS with an insufficient antioxidant response[203].
consequently, the indirect effects of NO are observed instead of its biological role.

4.4 Conclusion
The macrophage cell line RAW 264.7 is widely used as a positive control for NO
production and iNOS expression in tissue and cell culture. Moreover, previous work also
validated the temporal and spatial NO released from these cells cultured in high glucose
conditions. Therefore, it seemed fitting to use these cells to confirm the results obtained
from normal and wound fibroblasts cultured in similar conditions. The work presented here
proves that nitric oxide is significantly suppressed in cells cultured in high glucose
conditions and that the nitrite levels do not correlate with the actual NO levels that cells
experience in normal and high glucose cell culture conditions. The quantitative analysis
of continuous real-time NO measurements is of utmost importance when understanding the
role of NO especially in chronic pathological states and consequently can be used to
develop treatments that will not only deliver the adequate dose of NO but also address the
problem of increased oxidative and nitrosative stress, therefore increasing the
bioavailability of NO in the wound.
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5 CONCLUSION AND FUTURE WORK ON THE
RELEVANCE OF REAL-TIME NO MEASUREMENTS
Diabetes Mellitus remains one of the most challenging and complex pathologies of the 21st
century and individuals affected with DM are always at risk for the development of
complications such as DFU. The risks of amputations and death are significantly higher in
patients with DFU compared to patients without DFU. These wounds take a very long
time to heal because of the underlying metabolic condition of the patient as well as
persistent infections. Uncontrolled high glucose levels are characteristic for diabetic
patients who develop DFU and downstream it triggers several metabolic pathways that
interfere with the homeostatic environment that is necessary for the wound to heal. Nitric
oxide is essential in the wound healing process. It is produced by cells that are actively
present in the wound and is known to be involved in all the stages of wound healing. The
effects of NO are like a double aged sword. At low concentrations it modulates blood flow,
angiogenesis, cell proliferation, migration and activates various signaling pathways. While
at high concentrations it acts as a microbial agent to fight off infections in the wound. The
levels of NO need to be precisely controlled and this achieved by scavengers and
antioxidant systems under physiological conditions. Additionally, the timing of delivery is
of extreme importance in achieving normal physiological functioning. In diabetes, the high
levels of glucose interfere with the metabolism of NO through a number of mechanisms;
increased reactive oxygen species, reduced antioxidant levels, reduced co factors (NADPH,
BH4). The result is reduced bioavailability of NO and ultimately NO function. The
literature is vast on the effect of NO in the diabetic state however, the results reported are
contradictory. The role of NO is clearly defined in physiological conditions and even in
acute pathological states, the reported NO function is fairly consistent[190, 191, 223].
However, in regards to clinical application for chronic conditions such as DFU it still
remains a challenge. Nitric oxide in the wound needs to maintain an extremely delicate
balance when transitioning into different phases of the wound and this is achieved by a
complex cascade of events involving cross talk between the cells and the surrounding
matrix environment that act together to repair and restore the skin tissue barrier. Each of
these events require different doses/durations of NO. Nitric oxide is very reactive and short
lived. Understandably that makes it very difficult to measure and consequently the majority
of studies in the literature rely on its oxidized products (nitrate and nitrite) to predict the
NO function. This greatly under or over estimates the levels of NO that are actually needed
because it does not give any information on the dynamic change of NO in specific
conditions and how the NO levels change overtime. In addition, because of its reactivity
NO generates reactive nitrogen species especially in conditions of oxidative stress as is the
case of DFU. These RNS can also metabolize to produce nitrite/nitrate creating a
confounding effect/misinterpretation of NO function. Its therefore why we emphasize the
need to compare the actual levels of NO that cells produce and to see how well they
correlate with the nitrite/nitrate levels observed so as to determine if the effect observed is
primarily due to NO or other factors that interfere with its bioavailability and then proceed
accordingly. The work presented in this dissertation assessed the real-time NO levels and
nitrite produced from cells that are at the front line of the wound healing process under
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normal and high glucose conditions. In Chapter two, the NO produced from normal human
adult fibroblast cells was analyzed for normal and high glucose cell culture conditions in
the absence and presence of stimulation. The NO levels were found to be higher in normal
glucose compared to high glucose conditions when the cells were stimulated (8.42±1.16
and 3.26±0.79nmol/105 cells). The nitrite levels correlated to the real-time NO levels for
the cells in normal glucose conditions with and without stimulation. However, in high
glucose conditions, the NO levels were not statistically different in the absence and
presence of stimulation. The nitrite levels appeared higher but did not reach statistical
significance in high glucose with stimulation compared to cells without stimulation. The
iNOS protein was upregulated in all treatment groups but not statistically different. Further
studies would need to be performed to determine the mechanism involved in NO synthesis
in fibroblast cells. After determining the NO levels expected in normal fibroblast cells, we
adopted the same methodology to determine the NO produced from human adult wound
fibroblasts isolated from a chronic non-healing wound (1 year and 8 months). The NO
produced was slightly increased in normal glucose cells (4.08±3.38nmol/105) and yet
suppressed in high glucose conditions and the NO profile was also markedly different
compared to normal fibroblast cells. The nitrite/nitrate present in the wound bed was also
analyzed and found to be significantly higher (micromolar compared to nanomolar range)
compared to the NO levels produced from cells. The data suggests that there might be other
cells responsible for the nitrite/nitrate levels observed or other factors present in the wound
bed that interferes with NO function in the wound. The work from this chapter is part of
an ongoing clinical study to determine how the NO levels differ in diabetic and nondiabetic patients with chronic wounds. The data from chapter 4 looks at the NO produced
from the macrophage cell line RAW 264.7 which has been validated in previous studies
and was used to confirm NO and nitrite measurements obtained from normal and wound
fibroblasts cultured in normal and high glucose conditions. There was absence of NO
detected from cells cultured in normal and high glucose in the absence of stimulation.
When stimulated we observed a similar trend with normal glucose showing significantly
higher levels of NO compared to cells cultured in high glucose conditions (162± vs
46.25±1.29 nmols/106 cells). There was no significant difference of nitrite levels in normal
and high glucose with stimulation. The levels of the iNOS enzyme correlated with the realtime NO levels but not the nitrite. While the molecular pathways through which NO
availability is altered in diabetic conditions deserves further investigation than we can offer
in this dissertation, the conclusion can be drawn that in addition to analyzing NO
metabolites and NOS protein expression/levels, it is also fundamental to assess the
temporal and spatial aspects of NO in real-time to clearly and accurately define the NO
function in DFU. In the long term, it will facilitate engineering of precisely controlled NO
treatments that can model the physiological NO symphony in wound healing and repair the
damaged skin tissue.
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5.1 Future perspectives
We are at a precipice where the current research methodologies and treatment plans are
mainly focused on either the positive or detrimental effects of NO and yet undermine the
need for nitroso redox balance when treating chronic disease states. The use of real-time
NO measurements addresses this limitation by monitoring the precise moment when NO
affects different cell functions in a given experimental plan and then applying this
knowledge to determine the causal factors or modify the treatment according to the changes
observed.
5.1.1 The use of localized NO delivery systems to control the effect of NO
Now that we know the NO levels produced from normal wound fibroblasts and
macrophages cells. The challenge at hand is to determine whether we can incorporate the
NO levels measured in the cells into smart NO release wound dressings that can locally
deliver the correct doses of NO required for each cell population in a given sight of the
wound without altering the surrounding environment. Previously, an NO releasing
polymer system that incorporates an S-nitrosothiol compound (S-nitroso acetyl
penicillamine dimethyl siloxane (SNAP-PDMS)) was engineered in our lab that can be
finely tuned to deliver controlled doses of NO by photoinitiation[224]. A gradient target of
this polymer with varying concentrations of NO was prepared and applied to cells cultured
in the upper chamber of the CellNO trap device to deliver NO to those cells (Figure 5-1A).
The advantage of this system is that it allows us to deliver only NO to the cells so that when
compared to the real-time NO or nitrite accumulation, the effect observed will be specific
to either the dose of NO delivered or its bioavailability. Moreover, it can be modified to
simultaneously track the changes in real-time. In our preliminary study we used this
gradient as a localized NO treatment to assess the cell viability in the wound fibroblast
cells used in chapter 3. The data showed that the viability of the cells exposed to the highest
levels of NO was significantly reduced compared to cells exposed to lower doses of NO.
In the same culture chamber an area of the cells was not exposed to the NO gradient target
and these cells maintained over 95% cell viability (Figure 5-1B). The results clearly
indicated that we can adopt this model to treat the cells with varying concentrations of NO
that could have the potential to direct the migration and proliferation of cells from the
wound edge into the wound bed and reestablish the skin integrity.
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Figure 5-1 The treatment of wound fibroblasts with NO polymer gradient target.
Green and red represents live and dead cells respectively. Blue represents the
cell nuclei. The arrow represents the boundary between cells exposed and not
exposed to the NO treatment.
5.1.2

Quantitative monitoring of NO exposed to vascular smooth muscle
cell cultures for applications in cardiovascular calcification

Another application of the significance of real-time NO measurements is to determine the
role of NO in cardiovascular calcification which has become a growing burden in
westernized countries. Calcification has severe clinical consequences in diseases such as
calcific aortic valve disease, atherosclerosis, diabetes and chronic kidney disease [225,
226]. In a meta-analytical study based on the presence or absence of calcification, the risk
of any cardiovascular event, stroke and mortality in patients with heart disease, renal
insufficiency and diabetes mellitus increased 3-4-fold in the presence of calcification after
a 10 year follow up. The various treatment strategies that have been adopted to reduce the
global burden of cardiovascular diseases do not address the problem of ectopic
calcification. Nitric oxide has been proposed as a pharmaceutical option to halt the progress
of ectopic calcification[227]. However, the effects of NO reported in the literature are
controversial. Kanno et al [228] demonstrated that NO has an inhibitory role on vascular
calcification by down regulating TGF beta signaling. In another study, the NO donor
DETANO and valve endothelial cells had the same inhibitory effect on the calcification of
a valve interstitial cell culture[229]. However, Alsabeelah [230] showed that NO
aggravates vascular calcification through overexpression of iNOS enzyme. The drawback
of all these studies is that they used soluble NO donors and recent work has shown the
limitations of relying on the half-life of NO donors to investigate the biological role of
NO[153]. In addition, the studies lacked real time measurements on the actual level of NO
that cells experience at any given time in culture. The goal is to understand the role of NO
in cardiovascular calcification by using the CellNO trap measuring device that will
determine the actual level of NO that vascular smooth muscle cells are exposed to.
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Primary vascular smooth muscle cells were isolated from the thoracic aorta of a rat.
Immunofluorescent staining of the cell monolayers confirmed that the cell culture was
mainly composed of smooth muscle cells by the presence of smooth muscle α actin in the
cell cytoskeleton (Figure 5-2).

Figure 5-2 The characterization of primary smooth muscle cells. Green and blue
represents smooth muscle α actin and cell nuclei respectively. Scale bar 100µM

The method from Kanno et al[228] was adopted to show that NO inhibits cardiovascular
calcification when the cells are treated with 10µM of DETANO solution. The results
showed that cell cultures in complete growth medium in the absence and presence of NO
showed no signs of calcification. While the cells grown in osteogenic medium alone
showed early signs of calcification. The cells cultured in osteogenic medium that contained
the nitric oxide donor showed no signs of calcified nodule formation (Figure 5-3).
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Figure 5-3 Alizarin red staining of primary rat aortic smooth muscle cells in
culture for 14 days in (A) complete growth medium (control), (B) osteogenic
medium, (C) complete growth medium and 10 µM DETANO, and (D) osteogenic
medium and 10 µM DETANO. 20x magnification (scale bar 200 µm).
To determine the precise NO surface flux that the cells experience, we used the CellNO
trap device that was previously developed [152, 231]. Cells were taken from passage 3-5
and seeded at a density of 2.1×105 cells per well. At confluency, the medium was changed
and 10µM DETANO solution was added. The NO release was recorded for approximately
22 hours and cell viability in the device was confirmed by a live/dead assay using calcein
acetoxymethyl ester (calcein AM) and ethidium bromide dye. The NO release profile of
the NO donor alone in the device was recorded as well as the cells in the absence of the
NO donor. Nitric oxide released in the cell culture increased gradually reaching a peak of
approximately 0.05 picomoles /sec·cm2 and then decreased for a duration of 14 hours and
remained constant after 20 hours. The NO release profile of the NO donor in the absence
of cells followed the same trend but the level of NO recorded was lower compared to the
NO release in the presence of the cells. Interestingly, the cell culture in the absence of the
NO donor produced NO but in a much smaller quantity, reaching a peak of 0.01
picomoles/sec·cm2 (Figure 5-4). In previous studies, excess NO produced in vitro cell
culture was assumed to be responsible for the adverse effects experienced by the cells due
to the reaction of NO with reactive oxygen species[232, 233]. These data show how the
NO release profile in donors could change when added to cell cultures.
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Figure 5-4 The real-time NO detected in primary smooth muscle cells cultured in
media in the absence and presence of the NO donor DETANO
The ability to monitor this change in real time without altering the cell culture conditions
would possibly explain the difference in observed effects of NO in calcification. This is
the first study that has been able to achieve real time data on the actual level of NO that
primary vascular smooth muscle cells require to inhibit matrix mineralization. Further
investigation would involve assessing if the NO levels change in cells cultured in a
calcifying media in the absence and presence of the NO donor. In addition, iNOS protein
expression and the nitrite accumulation in the cell culture media needs to be analyzed and
compared to the real time NO levels measured. It is highly possible that the results reported
in the studies are consistent with the treatment delivered. However, the dose, duration and
when in the cell cycle that NO is delivered maybe a key player to distinguish the observed
effects of NO. The ability to determine this would require a highly controlled nitric oxide
delivery system that can be modulated on demand. The SNAP-PDMS gradient strip with
varying concentrations of the NO donor allows us to study dose effect simultaneously in
the same cell culture to accurately determine the critical point when NO changes from an
inhibitory to an aggravating effect on calcification. Real-time NO measurements will
provide the armamentarium needed for custom designed drug delivery systems that can be
applied to engineered constructs as well as pharmaceutical treatments to halt or slow down
the progress of complications associated with chronic disease states.
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Supplementary figures from Chapter 3

A.1

Western blot analysis

Figure A-1. Western blot analysis for eNOS protein in normal (NG and HG) and wound
fibroblasts cultured in normal (WN) and high glucose (WH)in the absence (-) and presence
(+) of stimulation. RAW 264.7 and human endothelial cells were used as positive controls
for iNOS and eNOS respectively. MOVAS cell line was used as a negative control for
eNOS. GAPDH was used as the housekeeping protein

Figure A-2. Western blot analysis to determine NF-κβ protein in wound fibroblasts
cultured in normal (NG) and high glucose (HG) in the absence (-) and presence (+) of
stimulation
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Supplementary
measurements
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Figure A-3 Minimum sensitivity for the nitrite/nitrate measurements

.

Figure A-4 Maximum sensitivity for the nitrite/nitrate measurements
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